{"text": "For age groups requiring one dose , cost - effectiveness ratios increase markedly if vaccination is initiated at the ninth or tenth week of the epidemic .", "label": "", "metadata": {}, "score": "29.09762"}
{"text": "For children who require two doses , vaccination may not be cost - effective if vaccine is delivered such that full protection is not achieved until after the 8 th week ( the peak ) of a hypothetical influenza season .", "label": "", "metadata": {}, "score": "29.998135"}
{"text": "Currently , the World Health Organization recommends the administration of 2 catch - up PCV10 doses at an interval of at least 2 months to unvaccinated children aged 12 - 24 months at the time of initial PCV10 vaccination [ 8 ] .", "label": "", "metadata": {}, "score": "33.658794"}
{"text": "Currently , the World Health Organization recommends the administration of 2 catch - up PCV10 doses at an interval of at least 2 months to unvaccinated children aged 12 - 24 months at the time of initial PCV10 vaccination [ 8].", "label": "", "metadata": {}, "score": "33.658794"}
{"text": "For example , vaccine programs serving populations with disease early in life , heavy transmission and young age of transmitters may prefer 3 + 0 schedules ; however , the data in our review do not provide a conclusive determination of which schedule is optimal for each of these settings .", "label": "", "metadata": {}, "score": "33.68165"}
{"text": "If vaccination is initiated beyond the tenth week into a hypothetical 16-week influenza season , the cost - effectiveness ratios become less favorable for subgroups requiring two doses .", "label": "", "metadata": {}, "score": "33.766262"}
{"text": "Results were sensitive to changes in the number of doses required for children , costs of vaccination , and timing of vaccine delivery .Requiring only one vaccine dose for children resulted in more favorable cost - effectiveness ratios compared to two doses .", "label": "", "metadata": {}, "score": "34.046207"}
{"text": "However , an accelerated schedule of 2 doses ( days 0 , 7 ) provides protection in up to 80 % of people .Persons previously immunised should have a booster after 3 years .", "label": "", "metadata": {}, "score": "34.284325"}
{"text": "Our analysis supports recent recommendations by the Pan American Health Organization and the World Health Organization for the use of 3 doses of PCV and the acceptability to be administered either as 3 + 0 or 2 + 1 schedule .", "label": "", "metadata": {}, "score": "34.618317"}
{"text": "4 Differences between the schedules are difficult to discern when comparing the impact of 2- and 3-dose primary series between studies rather than within studies .", "label": "", "metadata": {}, "score": "36.885036"}
{"text": "For the country as a whole , the estimated vaccine coverage of a complete 3-dose series during the first year of the vaccine introduction was approximately 90 % [ 28].", "label": "", "metadata": {}, "score": "37.09328"}
{"text": "In addition , SUS provided the vaccine for selected high risk individuals through its special immunization activities [ 20].N 2p+1 ( catch - up ) : a schedule of two doses for children aged 7- 11 months ( 7 - 11 m ) , with an interval of two months between doses ( minimum of 4 weeks ) plus a booster dose six months after the second dose .", "label": "", "metadata": {}, "score": "37.10294"}
{"text": "On the other hand , if only one dose is required for vaccinating children , the associated costs will be lower and cost - effectiveness ratios will be more favorable .", "label": "", "metadata": {}, "score": "37.151466"}
{"text": "Adequate protection against rabies requires 3 immunisations over 28 days with a schedule of day 0 , 7 and 28 .Preexposure immunisation is recommended for those who will be spending prolonged periods ( i.e. , more than one month ) in rural parts of rabies - affectedareas .", "label": "", "metadata": {}, "score": "37.54679"}
{"text": "A scenario analysis evaluated initiation of vaccination after the start of a hypothetical influenza season .Each week after the start of the season that vaccination was initiated was assumed to reduce the protective effect of the vaccine according to the expected distribution of cases over a hypothetical 16-week influenza season assuming peak at 9 weeks and 70 % of cases occur between weeks 7 - 10 .", "label": "", "metadata": {}, "score": "37.60165"}
{"text": "( 2 ) If only 3 doses are used , is there any evidence to prefer a 2 + 1 or a 3 + 0 schedule ?", "label": "", "metadata": {}, "score": "38.284454"}
{"text": "Recent evidence has shown that the administration of a booster dose after two primary doses reduces pneumococcal spread from older children to other members of the community [ 46].", "label": "", "metadata": {}, "score": "38.56997"}
{"text": "Recent evidence has shown that the administration of a booster dose after two primary doses reduces pneumococcal spread from older children to other members of the community [ 46 ] .", "label": "", "metadata": {}, "score": "38.56997"}
{"text": "Who Should Get Vaccinated and When ? PCV .The PCV is routinely given in four doses at 2 , 4 , 6 , and 12 - 15 months .", "label": "", "metadata": {}, "score": "38.880028"}
{"text": "Who Should Get Vaccinated and When ?The vaccine is recommended for most children aged 12 - 15 months .The second dose is given between ages 4 - 6 years .", "label": "", "metadata": {}, "score": "38.999973"}
{"text": "The present study was conducted early during the first year of PCV10 introduction as routine immunization .The following PCV10 schedules were evaluated : 3p+0 ( for children aged # 6 m ) ; 2p+0 ( for children aged 7 - 11 m ) ; and one catch - up dose ( for children aged 12 - 23 m ) .", "label": "", "metadata": {}, "score": "39.792614"}
{"text": "A second dose of hepatitis A vaccine is required 6 months after the first dose .Hepatitis B : Hepatitis B infection is very common in the Asia - Pacific area and vaccination against hepatitis B is essential for health - care staff .", "label": "", "metadata": {}, "score": "39.824318"}
{"text": "For lower attack rates , cost - effectiveness results were less favorable .Assuming an attack rate similar to that for an average influenza season ( 7.6 % ) , vaccination was no longer cost - saving for all high - risk subgroups .", "label": "", "metadata": {}, "score": "39.870827"}
{"text": "Fever .Drowsiness .Loss of appetite .Irritability .Acetaminophen is sometimes given to reduce pain and fever that may occur after getting a vaccine .", "label": "", "metadata": {}, "score": "39.884506"}
{"text": "However , the possibility of lacking power should be considered , as the analysis was stratified by dosing schedule .This reduced the sample size , leading to a wide 95%CI of PCV10 effectiveness , which might have not allowed the detection of an eventual reduction in vaccine - type carriage for this schedule .", "label": "", "metadata": {}, "score": "39.912457"}
{"text": "However , the possibility of lacking power should be considered , as the analysis was stratified by dosing schedule .This reduced the sample size , leading to a wide 95%CI of PCV10 effectiveness , which might have not allowed the detection of an eventual reduction in vaccine - type carriage for this schedule .", "label": "", "metadata": {}, "score": "39.912457"}
{"text": "The mainstay of control measures should be to provide appropriate treatment and improve water and sanitation , and community mobilisation .However , the WHO suggests that pre - emptive vaccination may play a role in preventing or containing outbreaks .", "label": "", "metadata": {}, "score": "40.671974"}
{"text": "Additionally , outside the US , adjuvanted vaccine was typically used and this formulation could result in a different risk profile than non - adjuvanted vaccine .", "label": "", "metadata": {}, "score": "40.99711"}
{"text": "Immunisations .Prior to travel to affected regions , 4 to 6 weeks is ideally required for a complete course of immunisations to be given .", "label": "", "metadata": {}, "score": "41.10308"}
{"text": "Assuming a higher overall attack rate of 30 % , cost - effectiveness ratios were less than $ 30,000/QALY for all age and risk groups for the full range of vaccination costs .", "label": "", "metadata": {}, "score": "41.13451"}
{"text": "Concerns regarding the immunogenicity of 2 + 0 schedules and the lack of evidence regarding the impact of 2 + 0 schedules on IPD , pneumonia and indirect effects have precluded its use in national immunization programs to date .", "label": "", "metadata": {}, "score": "41.291794"}
{"text": "These studies also did not consider the number of doses [ 13 ] , [ 14 ] , [ 17 ] , [ 18 ] , [ 35 ] .", "label": "", "metadata": {}, "score": "41.295074"}
{"text": "It is important to take into account any previous vaccines you have received and whether you have immunity from previous infection .The following vaccines are grouped into two categories .", "label": "", "metadata": {}, "score": "41.62723"}
{"text": "The Centers for Disease Control and Prevention ( CDC ) recommends that parents be advised of the risk of fever and seizure .Parents should be given the option to choose the combined or separate vaccine .", "label": "", "metadata": {}, "score": "41.985504"}
{"text": "Higher vaccination costs were associated with less favorable cost - effectiveness ratios for vaccination .Assuming the cost per dose to be twice that in the primary analysis resulted in cost - effectiveness ratios up to 68 % higher than the primary analysis , but cost - effectiveness ratios remained below $ 100,000/QALY .", "label": "", "metadata": {}, "score": "42.373802"}
{"text": "Cost - effectiveness ratios were 72 - 89 % lower for lower - risk children and vaccination remained cost - saving for high - risk children .", "label": "", "metadata": {}, "score": "42.604813"}
{"text": "Timing of vaccination affects the cost - effectiveness of vaccination and depended on when vaccination occurred and if the age group under consideration required one or two doses .", "label": "", "metadata": {}, "score": "42.661842"}
{"text": "Check your tetanus vaccination status : if you have a tetanus prone wound , and have had fewer than 3 doses of vaccine or more than 5 years has passed since your last dose you may need a booster vaccine and tetanus immune globulin .", "label": "", "metadata": {}, "score": "42.86003"}
{"text": "Comparisons between schedules show that 3 primary doses and a 2 + 1 schedule may reduce carriage more than 2 primary doses and a 2 + 0 schedule , respectively .", "label": "", "metadata": {}, "score": "43.001915"}
{"text": "Booster dose schedules ( 3p+1 and 2p+1 ) were not evaluated as the time period from vaccine introduction and case enrollment was short ( 6 - 8 months ) and children enrolled did not have the opportunity to have been exposed to the booster dose .", "label": "", "metadata": {}, "score": "43.446598"}
{"text": "Subjects will be actively monitored for 28 days following administration of vaccine or placebo ; monitoring will include medical history reviews , clinical assessments , and at some visits , nasal washes .", "label": "", "metadata": {}, "score": "43.54323"}
{"text": "The injections are usually given on Days 0 , 3 , 7 , 14 , 30 , and 90 .At the beginning of your treatment you may also receive a second injection with a rabies anti - serum or immune globulin ( im - YOON GLOB - yoo - lin ) .", "label": "", "metadata": {}, "score": "44.04598"}
{"text": "The level of risk depends on the mosquito population , season , location and duration of stay .The use of mosquito avoidance measures is essential at all times .", "label": "", "metadata": {}, "score": "44.083282"}
{"text": "We assumed full vaccination required 2 doses for individuals aged 6 months to 9 years and 1 dose for individuals aged 10 years and older .", "label": "", "metadata": {}, "score": "44.17647"}
{"text": "For lab workers / vaccine makers who work with live virus , check titers every 6 months ; for other high exposure patients ( veterinarians , animal control , cavers , etc . ) check every 2 years .", "label": "", "metadata": {}, "score": "44.21869"}
{"text": "For lab workers / vaccine makers who work with live virus , check titers every 6 months ; for other high exposure patients ( veterinarians , animal control , cavers , etc . ) check every 2 years .", "label": "", "metadata": {}, "score": "44.21869"}
{"text": "Dosing schedules for pneumococcal conjugate vaccine : considerations for policy makers .Pediatr Infect Dis J 33 Suppl 2 : S172 - 181 .Data provided are for informational purposes only .", "label": "", "metadata": {}, "score": "44.27355"}
{"text": "Other challenges include the feasibility of stockpiling of cholera vaccines , which require a cold chain , for a large campaign , and reaching a targeted population within a short period during a crisis .", "label": "", "metadata": {}, "score": "44.57483"}
{"text": "Vaccination - related costs included cost of pH1N1 vaccine doses , administration fees , and time costs ( for parents or patients , depending on the age of the vaccinee ) .", "label": "", "metadata": {}, "score": "44.64547"}
{"text": "( Table 4 ) .Discussion .We also find that pH1N1 vaccination is cost - saving for high - risk individuals less than 65 years under a wide range of assumptions .", "label": "", "metadata": {}, "score": "44.792637"}
{"text": "Supply of the pH1N1 vaccine was anticipated to be limited initially , raising questions of prioritization .Consideration of the economic consequences of a vaccination program for pH1N1 can aid decision makers in vaccine allocation decisions by providing information on the relative cost - effectiveness of vaccinating specific age and risk groups .", "label": "", "metadata": {}, "score": "44.951378"}
{"text": "assumed the use of adjuvanted vaccine for a US setting and is not directly comparable to our study due to assumed differences in effectiveness and side effect profile between the two formulations .", "label": "", "metadata": {}, "score": "45.073627"}
{"text": "Results .For vaccination initiated prior to the outbreak , pH1N1 vaccination was cost - saving for persons 6 months to 64 years under many assumptions .", "label": "", "metadata": {}, "score": "45.203743"}
{"text": "The economic evidence was consistent with target recommendations that were in place for pH1N1 vaccination .We also found that the delays in vaccine availability had a substantial impact on the cost - effectiveness of vaccination .", "label": "", "metadata": {}, "score": "45.39061"}
{"text": "Results .Assuming a 21 % overall attack rate and assuming that persons were fully vaccinated prior to the start of the outbreak , pH1N1 vaccination was cost - saving for all high - risk subgroups ages 6 months to 64 years .", "label": "", "metadata": {}, "score": "45.567276"}
{"text": "If individuals are more likely to seek medical attention if they think they have pH1N1 infection , these results represent a conservative approach to assessing the cost - effectiveness of vaccination .", "label": "", "metadata": {}, "score": "45.63154"}
{"text": "9 - 11 However , we lack a clear understanding of the full impact of reduced - dose schedules relative to 3 + 1 .One previous report reviewed clinical trials , cohort and case - control studies that made direct comparisons of various PCV schedules within each study ; however , only 2 studies from the large body of evidence on PCV and NP - carriage effects met the report 's inclusion criteria for NP - carriage evaluations .", "label": "", "metadata": {}, "score": "45.656296"}
{"text": "Recommended immunization schedules for persons aged 0 - 18 years - United States , 2008 .MMWR .2008;57;Q1-Q4 .Centers for Disease Control and Prevention , MMWR website .", "label": "", "metadata": {}, "score": "45.919106"}
{"text": "Considering that serotypes 6A and 19A are included within PCV13 , the use of this vaccine could further decrease carriage of common disease- causing serotypes .", "label": "", "metadata": {}, "score": "45.956398"}
{"text": "14 ] The probability of 7.6 % represents an average non - pandemic influenza season .Costs of influenza - related health events .Costs included direct medical costs for influenza events , including physician visits , over - the - counter and prescription medications , diagnostic tests , hospitalizations , and long - term sequelae , based on established costs for seasonal influenza .", "label": "", "metadata": {}, "score": "45.971893"}
{"text": "Considering herd immunity , the corresponding values would have been 2 920 deaths and 52 360 DALYs averted .The incremental costs per DALY averted of reactive vaccination were $ 2 770 and $ 370 , respectively , for vaccine price set at $ 5 and $ 1 .", "label": "", "metadata": {}, "score": "46.043472"}
{"text": "Main outcome and exposure of interest were PCV10 vaccine - type carriage and dosing schedules ( 3p+0 , 2p+0 , and one catch - up dose ) , respectively .", "label": "", "metadata": {}, "score": "46.38279"}
{"text": "Main outcome and exposure of interest were PCV10 vaccine - type carriage and dosing schedules ( 3p+0 , 2p+0 , and one catch - up dose ) , respectively .", "label": "", "metadata": {}, "score": "46.38279"}
{"text": "Main outcome and exposure of interest were PCV10 vaccine - type carriage and dosing schedules ( 3p+0 , 2p+0 , and one catch - up dose ) , respectively .", "label": "", "metadata": {}, "score": "46.38279"}
{"text": "Is there evidence to support the choice of PCV or PPV23 as a booster dose ?METHODS .Literature Search .This analysis is part of a larger project describing the impact of PCV dosing schedules on IPD , immunogenicity , NP carriage , pneumonia and indirect effects .", "label": "", "metadata": {}, "score": "46.43942"}
{"text": "[ 33 ] For the physician office setting , the proportion of persons vaccinated at an existing or vaccination - specific visit varied by age .", "label": "", "metadata": {}, "score": "46.453598"}
{"text": "However , many countries do not recommend vaccination in older age groups , nor have donors committed to supporting extended age group vaccination .To better inform decision - making , this systematic review examines the direct impact of extended age group vaccination in children over 12 months in low and middle income countries .", "label": "", "metadata": {}, "score": "46.586163"}
{"text": "In order to differentiate the booster dose from primary doses , we estimated the interval between doses ; any dose administered with an interval of at least 6 months was considered a booster dose .", "label": "", "metadata": {}, "score": "46.79323"}
{"text": "This analysis differs from dynamic models , which model the indirect effects of vaccination .One such model suggested that vaccinating school - aged children and adults between the ages of 30 and 40 would be most cost - effective .", "label": "", "metadata": {}, "score": "46.9662"}
{"text": "[34 ] The proportion of individuals receiving vaccination in a mass vaccination or physician office setting varied by age and risk group .Assumptions for mid - range costs for children also vary by age .", "label": "", "metadata": {}, "score": "47.34556"}
{"text": "Some studies have suggested higher costs of influenza vaccination in the physician office setting [ 39 ] , [ 40 ] , therefore , we also conducted a sensitivity analysis that assumed higher administration costs .", "label": "", "metadata": {}, "score": "47.366047"}
{"text": "Vaccination coverage was defined as the percentage of children who completed the recommended number of doses .Compliance with recommended schedules was defined as the percentage of children who received all valid doses at the NIP recommended time interval .", "label": "", "metadata": {}, "score": "47.61716"}
{"text": "Age - groups at 1 st PCV10 dose : we used the date of birth and the date at enrollment to assign children to each age - group .", "label": "", "metadata": {}, "score": "47.726196"}
{"text": "For the vaccination programme costs , we included vaccine purchase costs and vaccine delivery costs .For the base - case analyses , we assumed per - dose prices of US$ 1 and $ 5 and a 10 % vaccine wastage rate , but widely varied these assumptions in the sensitivity analysis .", "label": "", "metadata": {}, "score": "47.769493"}
{"text": "Topical steroids , topical antibiotic , and topical antifungal medications are acceptable within 24 hours of enrollment .May be reassessed after symptoms have resolved .", "label": "", "metadata": {}, "score": "48.001705"}
{"text": "Therefore , in this study , we were able to evaluate different dosing schedules before the administra- tion of the booster dose ( 2p+0 and 3p+0 , and also one catch - up dose ) .", "label": "", "metadata": {}, "score": "48.01069"}
{"text": "This schedule is for either the hepatitis B vaccine ( Engerix - B 10ug ) or hepatitis B / hepatitis A combination vaccine .Note : Engerix - B can also be given using a 0 , 1 , 2 , and 12 month schedule .", "label": "", "metadata": {}, "score": "48.088474"}
{"text": "Children younger than 5 years were assumed to be vaccinated in the physician office setting .Costs of adverse events were based on costs of adverse events associated with inactivated influenza vaccine .", "label": "", "metadata": {}, "score": "48.43844"}
{"text": "In addition , we explored sensitivity analyses relevant to the US decision maker perspective for costs of vaccination , influenza illness rates , and delays in vaccination using the best available information at the time of the pandemic .", "label": "", "metadata": {}, "score": "48.501884"}
{"text": "For example , in our base - case analysis , the costeffectiveness ratios that are based on four different combinations of vaccine price and assumptions on the presence of herd immunity ranged from cost - saving to $ 2 770 per DALY averted .", "label": "", "metadata": {}, "score": "48.60713"}
{"text": "Uncertainty exists as to the proportion of individuals likely to get vaccinated in each type of setting .Since costs of vaccination will vary with setting , these are key assumptions for the analysis .", "label": "", "metadata": {}, "score": "48.64392"}
{"text": "However , like any medicine , this vaccine can cause side effects but the risk of serious side effects is extremely low .Call your doctor at once if you have a serious side effect such as : . a very high fever , ( above 104 degrees ) ; . weakness or prickly feeling in your fingers or toes ; or . problems with balance or eye movement , trouble speaking or swallowing .", "label": "", "metadata": {}, "score": "49.115326"}
{"text": "The rationale behind this assumption based on results of efficacy trials in Hib vaccine on carriage which showed that high serum anti - capsular type are needed for prevention of mucosal colonization [ 33].", "label": "", "metadata": {}, "score": "49.191048"}
{"text": "Discuss the risks and benefits of taking acetaminophen with the doctor .PPSV .Half of the people who get the vaccine have mild side effects .", "label": "", "metadata": {}, "score": "49.264004"}
{"text": "For vaccine price , the break - even costs for cost - saving were $ 0.38 and $ 1.40 , respectively , with and without herd immunity ( Table III ) .", "label": "", "metadata": {}, "score": "49.441597"}
{"text": "Rate ratio / RR was calculated as the ratio between the prevalence of vaccine - types carriage in children exposed to different schedules and unvaccinated for PCV10 .", "label": "", "metadata": {}, "score": "49.48111"}
{"text": "Rate ratio / RR was calculated as the ratio between the prevalence of vaccine - types carriage in children exposed to different schedules and unvaccinated for PCV10 .", "label": "", "metadata": {}, "score": "49.48111"}
{"text": "Rate ratio / RR was calculated as the ratio between the prevalence of vaccine - types carriage in children exposed to different schedules and unvaccinated for PCV10 .", "label": "", "metadata": {}, "score": "49.48111"}
{"text": "Therefore , in this study , we were able to evaluate different dosing schedules before the administration of the booster dose ( 2p+0 and 3p+0 , and also one catch - up dose ) .", "label": "", "metadata": {}, "score": "49.524582"}
{"text": "Twenty - one ( 66 % ) evaluated PCV7 ; none used PCV10 or PCV13 .Five studies evaluated 2 primary doses and 13 three primary doses .", "label": "", "metadata": {}, "score": "49.534233"}
{"text": "Vaccination for pH1N1 influenza for children and young adults is cost - effective compared to other preventive health interventions under a wide range of scenarios .", "label": "", "metadata": {}, "score": "49.688"}
{"text": "Twenty - one ( 66 % ) studies evaluated PCV7 ; no studies evaluated PCV10 or PCV13 .Direct Comparisons of Dosing Schedules Within Studies : Clinical Trials .", "label": "", "metadata": {}, "score": "49.72918"}
{"text": "Vaccines may be harmful to an unborn baby and generally should not be given to a pregnant woman .However , not vaccinating the mother could be more harmful to the baby if the mother becomes infected with a disease that this vaccine could prevent .", "label": "", "metadata": {}, "score": "49.771843"}
{"text": "In conclusion , we found that PCV10 was associated with high protection against vaccine - type carriage with a 3p+0 and 2p+0 dosing schedules for children vaccinated before the first year of life , soon after vaccine introduction into the routine immunization schedule .", "label": "", "metadata": {}, "score": "50.10111"}
{"text": "In conclusion , we found that PCV10 was associated with high protection against vaccine - type carriage with a 3p+0 and 2p+0 dosing schedules for children vaccinated before the first year of life , soon after vaccine introduction into the routine immunization schedule .", "label": "", "metadata": {}, "score": "50.10111"}
{"text": "However , health care workers and pregnant women would be included as part of the overall high - risk and low - risk group calculations .", "label": "", "metadata": {}, "score": "50.26748"}
{"text": "Dosing schedules included 404 children ( 31.4 % ) who received 3p+0 ; 372 ( 28.9 % ) received 2p+0 ; 291 ( 22.6 % ) received a single dose , and 220 ( 17.1 % ) were not vaccinated .", "label": "", "metadata": {}, "score": "50.28067"}
{"text": "The timing of this vaccination is very important for it to be effective .Your individual booster schedule may be different from these guidelines .Follow your doctor 's instructions or the schedule recommended by the health department of the state you live in .", "label": "", "metadata": {}, "score": "50.301323"}
{"text": "The timing of this vaccination is very important for it to be effective .Your individual booster schedule may be different from these guidelines .Follow your doctor 's instructions or the schedule recommended by the health department of the state you live in .", "label": "", "metadata": {}, "score": "50.301323"}
{"text": "32 VT acquisition decreased over time in both the 2- and 3-dose primary regimens , but the groups were not directly compared .An observational follow - up study to a clinical trial in the Philippines compared children with pneumonia between 6 weeks and 23 months old , who had received PCV11 or placebo at a median age of 7 , 12 and 16 weeks .", "label": "", "metadata": {}, "score": "50.303642"}
{"text": "Keep track of any and all side effects you have after receiving this vaccine .When you receive a booster dose , you will need to tell the doctor if the previous shot caused any side effects .", "label": "", "metadata": {}, "score": "50.321045"}
{"text": "You will need to receive post - exposure prophylaxis ( if you have been immunised you still need to receive a shorter course of post - exposure prophylaxis - see immunisation section ) .", "label": "", "metadata": {}, "score": "50.44467"}
{"text": "A vaccination program for pH1N1 influenza for target groups can be justified from an economic perspective when indirect benefits are not considered and assuming that vaccine supplies are sufficient .", "label": "", "metadata": {}, "score": "50.488106"}
{"text": "Considerable uncertainty exists regarding the most likely setting for pH1N1 vaccination ( i.e. , mass vaccination clinics compared with physician offices ) .Therefore the primary analysis includes a mass vaccination setting , a physician office setting , and a \" mid - range \" cost setting that assumes a proportion of individuals is vaccinated in each setting .", "label": "", "metadata": {}, "score": "50.51198"}
{"text": "Persons previously immunised should be re - immunised after 3 years .Varicella vaccine is recommended for non - immune workers ( those with no definite history of chickenpox or negative serology ) .", "label": "", "metadata": {}, "score": "50.71032"}
{"text": "Emerging data on the epidemiology of pH1N1 influenza virus infection were used in the simulation model where available , but some assumptions were based on data from seasonal influenza .", "label": "", "metadata": {}, "score": "50.792213"}
{"text": "A single dose of meningococcal polysaccharide vaccine ( Mencevax or Menomune ) provides protection against 4 strains of meningococcal bacteria ( A , C , W135 and Y ) for about 3 years .", "label": "", "metadata": {}, "score": "50.81772"}
{"text": "Methodology .A computer simulation model was developed to predict costs and health outcomes for a pH1N1 vaccination program using inactivated vaccine compared to no vaccination .", "label": "", "metadata": {}, "score": "50.888016"}
{"text": "The live attenuated formulation is not explicitly included in the current analysis .Live attenuated vaccine for seasonal influenza may be more effective than inactivated vaccine for young children [ 47 ] , yet recent data suggest that inactivated vaccines may be more effective for young adults [ 48 ] .", "label": "", "metadata": {}, "score": "50.916283"}
{"text": "Alternatively adult diphtheria - tetanus vaccine ( known as ADT or dT ) can be given .Typhoid vaccine is recommended as a single dose intramuscular ( IM ) injection or as a combination typhoid / hepatitis A IM vaccine .", "label": "", "metadata": {}, "score": "51.457733"}
{"text": "Few are conducted in regions where child mortality is high , and some studies were in the setting of catch - up campaigns , which would blur the measured effect of the primary schedule .", "label": "", "metadata": {}, "score": "51.47695"}
{"text": "7 , 27 , 29 , 38 , 43 , 46 , 50 These 10 trials included 23 study arms .All 5 arms evaluating a 2-dose primary series found reductions in VT - carriage prevalence among PCV recipients compared with controls , although only 1 arm reached statistical significance .", "label": "", "metadata": {}, "score": "51.619972"}
{"text": "The primary analysis assumes that some individuals will receive pH1N1 vaccination at an existing physician visit which would be associated with lower administration costs .An existing visit is defined as a visit previously - scheduled for a purpose other than pH1N1 vaccination .", "label": "", "metadata": {}, "score": "51.906536"}
{"text": "Are very ill .What Other Ways Can Pneumococcal Disease Be Prevented Besides Vaccination ?What Happens in the Event of an Outbreak ?In the event of an outbreak , all people who are eligible for a vaccine should receive it .", "label": "", "metadata": {}, "score": "52.041294"}
{"text": "Hepatitis A : This is a common food- and water - borne pathogen .Hepatitis A vaccine given 2 weeks prior to departure will provide adequate protection and is available in 3 formulations : alone , in combination with hepatitis B vaccine , or in combination with typhoid vaccine .", "label": "", "metadata": {}, "score": "52.203743"}
{"text": "However , two key outcomes with longer - term effects , influenza - related deaths and long - term sequelae of influenza - related illness , were included .", "label": "", "metadata": {}, "score": "52.274597"}
{"text": "Repellents should be re - applied at least every 4 hours , depending on amount of sweating .Sleep under a mosquito bed net , preferably one that has been treated with permethrin insecticide .", "label": "", "metadata": {}, "score": "52.372078"}
{"text": "This vaccine is injected into a muscle .You will receive this injection in a doctor 's office or clinic setting .For preventing rabies if you are at risk of exposure , you will need to receive a total of 3 injections .", "label": "", "metadata": {}, "score": "52.3992"}
{"text": "38 ] The primary analysis explored a range of values for pH1N1 illness rates and vaccination costs due to uncertainty regarding the severity of the pH1N1 influenza season and preferred vaccination settings .", "label": "", "metadata": {}, "score": "52.613926"}
{"text": "Most studies have taken advantage of clinical trials to assess pneumococcal colonization as an outcome of interest .After vaccine introduction , one of the proposed methods to assess vaccine effectiveness on pneumococcal carriage is repeated sampling of the same individuals over time , which is expensive and invasive [ 24 ] .", "label": "", "metadata": {}, "score": "52.66677"}
{"text": "Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine ( PPSV23 ) .MMWR Morb Mortal Wkly Rep. 2010;59(34):1102 - 1106 .", "label": "", "metadata": {}, "score": "52.703312"}
{"text": "Usual Pediatric Dose for Rabies Prophylaxis : .Pre - Exposure Prophylaxis : -Primary vaccination : 3 doses , 1 mL each , IM , on days 0 , 7 , and 21 or 28 -Booster vaccination : 1 dose , 1 mL , IM .", "label": "", "metadata": {}, "score": "52.7649"}
{"text": "Data on sociodemographic characteristics and factors potentially associated with PCV10 effectiveness on vaccine - type carriage such as day - care attendance , number of children living in the same household , mother 's schooling , and access to private health insurance were collected .", "label": "", "metadata": {}, "score": "52.990948"}
{"text": "Talk to your doctor .If you have certain conditions , you will not be able to get the vaccine .If you or your child has not been vaccinated but has been exposed to chickenpox , getting vaccinated within three days can help reduce the virus or offer protection from the infection .", "label": "", "metadata": {}, "score": "52.996025"}
{"text": "2011;8:e1001017 .Dagan R , Givon - Lavi N , Porat N , et al .The effect of an alternative reduced - dose infant schedule and a second year catch - up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage : a randomized controlled trial .", "label": "", "metadata": {}, "score": "53.04071"}
{"text": "Accessed August 29 , 2013 .Recommended immunization schedule for persons aged 0 through 18 years-2013 .Centers for Disease Control and Prevention website .Accessed August 27 , 2013 .", "label": "", "metadata": {}, "score": "53.116207"}
{"text": "Coverage of DTP - Hib was used for comparison purposes .Overall , vaccination coverage was 54.6 % ( 95 % CI 52.1 - 57.7 % ) , lower than DTP - Hib coverage ( 93.0 % ; 95 % CI 91.5 - 94.3 % ) .", "label": "", "metadata": {}, "score": "53.133068"}
{"text": "Serotypes 1 , 5 and 7F were not detected .The characteristics of 1,287 children according to vaccination status are shown in Table 3 .Unvaccinated and vaccinated groups Table 1 .", "label": "", "metadata": {}, "score": "53.256485"}
{"text": "The strengths of this analysis are its comprehensive nature with the diversity of countries and study designs included .Very few NP studies directly compare schedules , and this analysis allows for all of the supporting evidence for each of these regimens to be considered .", "label": "", "metadata": {}, "score": "53.34597"}
{"text": "Of these , 179 ( 36.2 % ) carried PCV10 vaccine - types .Overall , 35 serotypes were identified among the 494 isolates tested , with the proportions of serotypes covered by PCV10 and PCV13 estimated at 36.2 % and 53.0 % , respectively .", "label": "", "metadata": {}, "score": "53.366467"}
{"text": "Serotypes 1 , 5 and 7F were not detected .The characteristics of 1,287 children according to vaccination status are shown in Table 3 .Table 5 shows the results of PCV10 effectiveness for pneumococcal carriage vaccine - types in a multiple regression model .", "label": "", "metadata": {}, "score": "53.42672"}
{"text": "Side effects may include : .Redness or pain at the injection site .Fever .Muscle aches .Severe allergic reactions - rare .Who Should Not Get Vaccinated ?", "label": "", "metadata": {}, "score": "53.47602"}
{"text": "However , at 5 and 15 months , the VT carriage prevalence was not significantly different among children who received 2 and 3 doses .44 The third study , conducted in Israel with PCV7 , compared a 3 + 1 schedule ( 2 , 4 , 6 and 12 months ) with 2 + 1 ( 4 , 6 and 12 months ) and 0 + 2 ( 12 and 18 months ) schedules .", "label": "", "metadata": {}, "score": "53.677837"}
{"text": "A cohort study from Korea evaluated the effect of a 3 + 1 schedule ( given at 2 , 4 , 6 and 16.5 months ) , following PCV7 private - market introduction .", "label": "", "metadata": {}, "score": "53.72837"}
{"text": "[53 ] Khazeni et al .( 2009 ) evaluate the cost - effectiveness of vaccination against pandemic influenza A ( H1N1 ) for a major US metropolitan city and early vaccination to be cost - saving .", "label": "", "metadata": {}, "score": "53.815887"}
{"text": "The primary outcome measure was incremental cost per DALY averted .A crucial issue in estimating the cost - effectiveness of mass vaccination campaigns using oral cholera vaccines is whether they provide herd immunity effects and , if so , how the level of potential herd immunity depends on vaccine coverage .", "label": "", "metadata": {}, "score": "53.94373"}
{"text": "Studies were included for abstraction if PPV23 was used as a booster dose , but not if used as a primary dose .Titles and abstracts were reviewed twice and those with relevant content on 1 of the 5 outcomes ( immunogenicity , carriage , invasive disease , pneumonia and indirect effects ) underwent full review using a standardized data collection instrument .", "label": "", "metadata": {}, "score": "53.94921"}
{"text": "Such an approach also makes the assumption that society is willing to accept health risks of vaccine adverse events for school - aged children in return for health benefits to adults and younger children .", "label": "", "metadata": {}, "score": "54.087852"}
{"text": "Vaccine .Conklin L , Loo JD , Kirk J , et al .Systematic review pneumococcal conjugate vaccine dosing schedules on vaccine - type invasive pneumococcal disease among young children .", "label": "", "metadata": {}, "score": "54.122597"}
{"text": "PPSV should also be given to any adult aged 19 to 64 years old who : .In some cases , a second dose of PPSV may be needed .", "label": "", "metadata": {}, "score": "54.205414"}
{"text": "Because no previous observational study has evaluated the effectiveness of 3p+0 or 2p+0 PCV10 dosing schedules on pneumococcal carriage , comparison of our findings is hampered .", "label": "", "metadata": {}, "score": "54.29707"}
{"text": "Because no previous observational study has evaluated the effectiveness of 3p+0 or 2p+0 PCV10 dosing schedules on pneumococcal carriage , comparison of our findings is hampered .", "label": "", "metadata": {}, "score": "54.29707"}
{"text": "[ 37 ] Given that the inclusion of herd effects would result in an increase in the health benefits associated with vaccination , an extension of the current analysis to include herd effects would result in more favorable cost - effectiveness results .", "label": "", "metadata": {}, "score": "54.421867"}
{"text": "Seventy children ( 5.4 % ) attended day - care and 832 ( 64.6 % ) used the public health insurance exclusively .The distribution of children between age - group at enrollment and age - group at 1stPCV dose is displayed on Table 2 .", "label": "", "metadata": {}, "score": "54.476837"}
{"text": "The present study adds to the body of evidence describing PCV10 effects on NP carriage following different dosing schedules .Our data indicate that the primary series of either 3p+0 or 2p+0 dosing are effective in reducing PCV10 vaccine - type carriage .", "label": "", "metadata": {}, "score": "54.55265"}
{"text": "The present study adds to the body of evidence describing PCV10 effects on NP carriage following different dosing schedules .Our data indicate that the primary series of either 3p+0 or 2p+0 dosing are effective in reducing PCV10 vaccine - type carriage .", "label": "", "metadata": {}, "score": "54.55265"}
{"text": "The exclusion of vaccination - related adverse events would yield more favorable results for vaccination compared with a more comprehensive analysis that included adverse events .", "label": "", "metadata": {}, "score": "54.588005"}
{"text": "An intervention is defined as cost - effective if it results in an increase in both costs and QALYs and the resulting ratio is less than a determined threshold .", "label": "", "metadata": {}, "score": "54.67382"}
{"text": "The main outcome of interest ( exposure variable ) was pneumococcal carriage of PCV10 vaccine type .Unvaccinated and vaccinated groups were compared regarding the following variables potentially associated with colonization : age - group ( at enrollment ) , gender , number of children living in the same household , mother 's schooling , and day - care attendance .", "label": "", "metadata": {}, "score": "54.808304"}
{"text": "Depending on your risk of exposure to rabies , you may need to receive the rabies vaccine series every 2 years .If you work around live rabies virus , such as in a laboratory or a vaccine production area , you may need to receive a booster rabies vaccine every 6 months .", "label": "", "metadata": {}, "score": "54.80891"}
{"text": "Sensitivity analyses explored changes in key variables including the number of doses required for vaccination , costs of vaccination , vaccination - related adverse events , and influenza - related hospitalization rates .", "label": "", "metadata": {}, "score": "54.926094"}
{"text": "If not reported , we calculated the difference in carriage between vaccinated children and controls .We separated clinical trials into those that directly compared NP effects of various schedules and trials that evaluated effects only between a given schedule and unvaccinated controls .", "label": "", "metadata": {}, "score": "55.016293"}
{"text": "A second dose is also recommended for people 2 through 64 who have : .A damaged spleen or no spleen .Sickle cell disease .", "label": "", "metadata": {}, "score": "55.021275"}
{"text": "Probabilities of hospitalization and death following pH1N1 illness were derived from emerging data for pH1N1 in spring / summer 2009 .One intermediate probability , 21 % , represents the most recent estimate for the pH1N1 pandemic derived from Shrestha et al ( 2011 ) .", "label": "", "metadata": {}, "score": "55.034634"}
{"text": "Armstrong BG , Mangtani P , Fletcher A , Kovats S , McMichael A , et al .( 2004 )Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza : cohort study in elderly people .", "label": "", "metadata": {}, "score": "55.05831"}
{"text": "One 3-dose primary series arm ( Merck , PCV7 ) observed a nonsignificant increase of VT - carriage prevalence at 7 months of age .", "label": "", "metadata": {}, "score": "55.10115"}
{"text": "We also defined \" study arms \" as a group of children distinguished by immunization schedule or PCV product .We abstracted core information on the following : number of children in a \" study arm \" ; PCV manufacturer , valency and conjugate protein ; co - administered vaccines ; country ; age at each dose and date of study and publication .", "label": "", "metadata": {}, "score": "55.13076"}
{"text": "A recent systematic review of clinical trials assessing pneumococcal NP carriage provided evidence of decreased vaccine - type carriage for 2p+0 , 2p+1 , 3p+0 and 3p+1 schedules compared with no vaccine uptake , with the reduction greatest for the 3 primary dosing schedule [ 37 ] .", "label": "", "metadata": {}, "score": "55.18627"}
{"text": "Fiore AE , Uyeki TM , Broder K , Finelli L , Euler GL , et al .( 2010 )Prevention and control of influenza with vaccines : recommendations of the Advisory committee on Immunzation Practices ( ACIP ) , 2011 .", "label": "", "metadata": {}, "score": "55.21472"}
{"text": "Most studies have taken advantage of clinical trials to assess pneumo- coccal colonization as an outcome of interest .After vaccine introduction , one of the proposed methods to assess vaccine effectiveness on pneumococcal carriage is repeated sampling of the same individuals over time , which is expensive and invasive [ 24].", "label": "", "metadata": {}, "score": "55.30826"}
{"text": "Combining the health and cost outcomes , without herd immunity , under the base - case assuming $ 5 per vaccine dose , the estimated incremental cost per DALY averted was $ 2 770 .", "label": "", "metadata": {}, "score": "55.330315"}
{"text": "28 , 48 The available evidence does not support the use of schedules with PPV23 boosters for improving NP - carriage reductions .Determining the relative benefit for NP - carriage reductions of 1 schedule over another is difficult .", "label": "", "metadata": {}, "score": "55.52406"}
{"text": "Injection site reactions , systemic reactions , anaphylaxis , and Guillain Barr\u00e9 syndrome varied by age and are listed in Table S1 .Incidence of Guillain Barr\u00e9 syndrome was based on data from seasonal influenza vaccine [ 22 ] and varied in sensitivity analyses to reflect rates observed in the 1976 swine flu vaccination program .", "label": "", "metadata": {}, "score": "55.650528"}
{"text": "Although PCV10 coverage rapidly increased shortly after vaccination introduction , it was not matched by compliance with recommended schedules .Public initiatives should target compliance of PCV10 because of the burden of pneumococcal diseases on childhood morbidity and mortality .", "label": "", "metadata": {}, "score": "55.656853"}
{"text": "18 Furthermore , only 7 NP studies evaluated PCV schedule impact in children at high risk for colonization and disease ; the only study to specifically evaluate children with HIV failed to show efficacy of a 3 + 0 schedule on VT carriage .", "label": "", "metadata": {}, "score": "55.666912"}
{"text": "Children who should not receive the vaccine are those who : .Have had a life - threatening allergic reaction to a previous dose of PCV .", "label": "", "metadata": {}, "score": "55.73591"}
{"text": "[ Time Frame : Measured through Day 28 ] [ Designated as safety issue : Yes ] .Proportion of participants that develop 4-fold or greater rises in RSV neutralizing antibody titer following vaccination [ Time Frame : Measured through study follow - up period , up to 1 year after study entry ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "55.80529"}
{"text": "Data Collection .During home visits , a standardized questionnaire was administered to legal guardians of all children included in the study .Data on sociodemographic characteristics and factors potentially associated with PCV10 effectiveness on vaccine - type carriage such as day - care attendance , number of children living in the same household , mother 's schooling , and access to private health insurance were collected .", "label": "", "metadata": {}, "score": "55.86422"}
{"text": "Results were most sensitive to case - fatality rate , per - dose vaccine price , and the size of the outbreak .CONCLUSION : Reactive vaccination has the potential to be a costeffective measure to contain cholera outbreaks in countries at high risk .", "label": "", "metadata": {}, "score": "55.903023"}
{"text": "Required coverage rates to generate herd effects for pH1N1 are unknown and substantial uncertainty exists for the required minimum coverage level for seasonal influenza [ 49 ] , [ 50 ] , [ 51 ] .", "label": "", "metadata": {}, "score": "56.045734"}
{"text": "Tocheva AS , Jefferies JM , Rubery H , Bennett J , Afimeke G , et al .( 2011 )Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children .", "label": "", "metadata": {}, "score": "56.17348"}
{"text": "The distribution of children between age - group at enrollment and age - group at 1 st PCV dose is displayed on Table 2 .The majority of children enrolled ( 53.7 % ) received the 1 st dose of PCV10 at the first semester of life .", "label": "", "metadata": {}, "score": "56.225067"}
{"text": "Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children .Vaccine 29 : 4400 - 4404 .", "label": "", "metadata": {}, "score": "56.293156"}
{"text": "Pisu M , Meltzer JI , Hurwitz ES , Haber M ( 2005 ) Household - based costs and benefits of vaccinating healthy children in day care against influenza virus : results from a pilot study .", "label": "", "metadata": {}, "score": "56.384216"}
{"text": "Licensure of a 13-Valent pneumococcal conjugate vaccine ( PCV13 ) and recommendations for use among children .MMWR Recomm Rep. 2010;59(RR-11):1 .Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years - United States , 2014 .", "label": "", "metadata": {}, "score": "56.54237"}
{"text": "This study will evaluate the safety and immunogenicity of an RSV vaccine in healthy RSV - na\u00efve children .At study entry , participants will undergo a medical history review , physical examination , blood collection , and a nasal wash .", "label": "", "metadata": {}, "score": "56.555782"}
{"text": "Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine .MMWR Morb Mortal Wkly Rep. 2010;59(34):1102 .", "label": "", "metadata": {}, "score": "56.647842"}
{"text": "17 suggest that mass vaccination using oral cholera vaccines can confer indirect protection to unvaccinated individuals .Assumptions on resource use .To estimate the resource use associated with a hypothetical reactive vaccination programme , we considered direct medical costs ( vaccination programme costs and medical treatment costs ) only , not including direct non - medical costs such as transportation and patient time costs .", "label": "", "metadata": {}, "score": "56.74662"}
{"text": "Alternatively , use water purification tablets ( e.g. , iodine or chlorine tablets ) and use as per the instructions on pack .Food : Care should be taken with the source of food - hot food should be truly hot , fruit should be peeled yourself , cold food truly cold ( and best avoided ) .", "label": "", "metadata": {}, "score": "56.816975"}
{"text": "Prosser LA , Bridges CB , Uyeki TM , Rego VH , Ray GT , et al .( 2005 )Values for preventing influenza - related morbidity and vaccine adverse events in children .", "label": "", "metadata": {}, "score": "56.996025"}
{"text": "Long - term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae , S. aureus , H. influenzae and M. catarrhalis .PLoS One 7 : e39730 .", "label": "", "metadata": {}, "score": "57.108467"}
{"text": "Comparison to Other Economic Studies of pH1N1 Vaccination .Estimates of the economic impact of vaccination are available for the US and other countries .In the US , Beigi et al .", "label": "", "metadata": {}, "score": "57.13195"}
{"text": "Higher risk groups were defined using conditions identified by CDC as placing individuals at higher risk for medical complications of influenza illness .[ 6 ] .", "label": "", "metadata": {}, "score": "57.200813"}
{"text": "19 , 54 Results suggest that the 2 + 1 schedule results in similar VT - carriage prevalence to 3 + 1 when VT - carriage prevalence is sampled after the booster doses ; however , 2 + 1 appears to be inferior to 3 + 1 prior to the booster dose .", "label": "", "metadata": {}, "score": "57.287727"}
{"text": "Two observational studies examined 2 + 1 schedules .One conducted in England with national introduction with a catch - up campaign showed a statistically significant reduction .", "label": "", "metadata": {}, "score": "57.341026"}
{"text": "[49 ] , [ 50 ] , [ 51 ] Another rationale for restricting the analysis to individual - level benefits relates to societal preferences .", "label": "", "metadata": {}, "score": "57.425507"}
{"text": "Long - term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae- and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization - in HIV - Infected and HIV - uninfected children .", "label": "", "metadata": {}, "score": "57.457848"}
{"text": "At that time , target groups for vaccination were identified by the Centers for Disease Control and Prevention 's Advisory Committee for Immunization Practices ( ACIP ) .", "label": "", "metadata": {}, "score": "57.734756"}
{"text": "O'Brien KL , Wolfson LJ , Watt JP , Henkle E , Deloria - Knoll M , et al .( 2009 )Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years : global estimates .", "label": "", "metadata": {}, "score": "57.762276"}
{"text": "Vaccine 28 : 6210 - 6220 .", "label": "", "metadata": {}, "score": "57.7662"}
{"text": "doi : 10.1016/j.vaccine.2010.12.086 .Auranen K , Rinta - Kokko H , Halloran ME ( 2013 ) Estimating strain - specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross - sectional study .", "label": "", "metadata": {}, "score": "57.90654"}
{"text": "Auranen K , Rinta - Kokko H , Halloran ME ( 2013 ) Estimating strain - specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross- sectional study .", "label": "", "metadata": {}, "score": "58.011967"}
{"text": "Links ] .Jeuland M , Cook J , Poulos C , Clemens J , Whittington D , DOMI Cholera Economics Study Group .Costeffectiveness of new - generation oral cholera vaccines : A multisite analysis .", "label": "", "metadata": {}, "score": "58.0477"}
{"text": "Rabies vaccine dosing information .Pre - Exposure Prophylaxis : -Primary vaccination : 3 doses , 1 mL each , IM , on days 0 , 7 , and 21 or 28 -Booster vaccination : 1 dose , 1 mL , IM .", "label": "", "metadata": {}, "score": "58.05427"}
{"text": "( Table S4 ) .Results were not sensitive to changes in the probability of Guillain - Barr\u00e9 syndrome following vaccination when varying the probability up to 1 in 100,000 .", "label": "", "metadata": {}, "score": "58.0775"}
{"text": "[52 ] Results of sensitivity analysis varying the costs of vaccination could provide useful information for future decision making given the sensitivity of the results to this input parameter .", "label": "", "metadata": {}, "score": "58.087097"}
{"text": "Nuorti JP , Whitney CGCenters for Disease Control and Prevention ( CDC ) .Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices ( ACIP ) .", "label": "", "metadata": {}, "score": "58.093693"}
{"text": "What Are the Risks Associated With the Pneumococcal Vaccine ?PCV .Generally , all vaccines have a small risk of serious problems .Side effects of PCV include : .", "label": "", "metadata": {}, "score": "58.129723"}
{"text": "BACKGROUND : To contain ongoing cholera outbreaks , the World Health Organization has suggested that reactive vaccination should be considered in addition to its previous control measures .", "label": "", "metadata": {}, "score": "58.399345"}
{"text": "Preventing pneumococcal disease among infants and young children .Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) .MMWR Recomm Rep 49 : 1 - 35 .", "label": "", "metadata": {}, "score": "58.441494"}
{"text": "DISCUSSION .We found that all schedules reviewed-2 + 0 , 2 + 1 , 2 + 1PPV23 , 3 + 0 , 3 + 1 and 3 + 1PPV23-reduced carriage of VTs of pneumococcus compared with no PCV .", "label": "", "metadata": {}, "score": "58.48925"}
{"text": "Pilishvili T , Lexau C , Farley MM , Hadler J , Harrison LH , et al .( 2010 ) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine .", "label": "", "metadata": {}, "score": "58.49302"}
{"text": "3 illustrates the two - way sensitivity analysis results using two of the influential parameters , vaccine price and total cholera treatment costs .Table IV presents selected results of a scenario analysis in which a comprehensive set of key variables / assumptions were varied over plausible ranges , in combinations taking into account correlations among different variables / assumptions .", "label": "", "metadata": {}, "score": "58.54357"}
{"text": "Minimise dehydration by taking an oral rehydration solution ( e.g. , Gastrolyte \u00ae tablets / sachets in water ) .If no fever or bloody stools , use loperamide ( as per instructions on the pack ) .", "label": "", "metadata": {}, "score": "58.573677"}
{"text": "Characteristics associated with unvaccinated and vaccinated children with PCV10 .doi:10.1371/journal.pone.0098128 .t003 Table 4 .Rate ratio of PCV10 dosing schedule according to pneumococccal vaccine - type nasopharyngeal carriage .", "label": "", "metadata": {}, "score": "58.5742"}
{"text": "Dagan R , Zamir O , Tirosh N , et al .Nasopharyngeal ( NP ) carriage of Streptococcus pneumoniae ( Pnc ) in toddlers vaccinated during infancy with an 11 valent pneumococcal vaccine conjugated to diphtheria and tetanus toxoids ( PCV - DT ) .", "label": "", "metadata": {}, "score": "58.908367"}
{"text": "The varicella vaccine , like all vaccines , can cause problems , such as severe allergic reaction .The risk of serious harm or death is extremely small .", "label": "", "metadata": {}, "score": "58.93724"}
{"text": "Geographic region , socioeconomic level and other factors affect carriage of pneumococci and thus confound our ability to compare magnitudes of impact across studies .Additionally , we were unable to account for vaccine coverage in the target populations or the presence of catch - up campaigns due to limited information in the study reports .", "label": "", "metadata": {}, "score": "59.226276"}
{"text": "Kristinsson KG , Sigurdardottir ST , Gudnason T , et al .Effect of vaccination with octavalent protein conjugated pneumococcal vaccines on pneumococcal carriage in infants .", "label": "", "metadata": {}, "score": "59.39387"}
{"text": "Pneumococcal conjugate vaccines ( PCV ) have been available for over a decade but only recently were introduced into national immunization programs of developing countries .", "label": "", "metadata": {}, "score": "59.39414"}
{"text": "Pneumococcal conjugate vaccines ( PCV ) have been available for over a decade but only recently were introduced into national immunization programs of developing countries .", "label": "", "metadata": {}, "score": "59.39414"}
{"text": "Uncertainty analysis .In the one - way sensitivity analysis , the results were most sensitive to CFR , per - dose vaccine price and the size of epidemic ( i.e. total number of cholera cases ) , regardless of consideration of herd immunity ( Fig . 2 ) .", "label": "", "metadata": {}, "score": "59.466072"}
{"text": "Loo JD , Conklin L , Fleming Dutra KE .Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization .", "label": "", "metadata": {}, "score": "59.472202"}
{"text": "Is less than 5 years old and was given PCV7 , which is an earlier version of the vaccine .PPSV .The PPSV is given to adults aged 65 and older .", "label": "", "metadata": {}, "score": "59.4873"}
{"text": "[17 ] .Vaccination assumptions .Pandemic H1N1 vaccine effectiveness was assumed to have similar effectiveness as for seasonal influenza vaccine based on preliminary studies of 2009 pH1N1 vaccine immunogenicity which shows immune responses comparable to seasonal influenza vaccine .", "label": "", "metadata": {}, "score": "59.574413"}
{"text": "Malaria preventive therapy is required for many countries on the Asia - Pacific area .Following a disaster , malaria may become resurgent in some areas where it has not recently been a problem .", "label": "", "metadata": {}, "score": "59.614803"}
{"text": "( 2007 ) Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA : a time - series analysis .Lancet 369 : 1179 - 1186 .", "label": "", "metadata": {}, "score": "59.67434"}
{"text": "Data analysis .Statistical analyses were performed using the STATA software , version 12.0 ( Stata Corp , College Station , TX ) .The distribution of children according to age - group at recruitment and at 1 st PCV10 dose was compared .", "label": "", "metadata": {}, "score": "59.6874"}
{"text": "We obtained the loss in QALYs associated with each influenza - related health event from published studies and primary data .( Tables S1 , S2 ) .", "label": "", "metadata": {}, "score": "59.800278"}
{"text": "Immobilisation without pressure bandaging is recommended for snake bites in Asia unless you definitely know whether the snake is one with neurotoxic venom .After transport to a health facility for assessment , the management and use of antivenom will depend on local protocols and antivenom availability for snakes from that region .", "label": "", "metadata": {}, "score": "59.85619"}
{"text": "Hammitt LL , Bruden DL , Butler JC , et al .Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae : an explanation of trends in invasive pneumococcal disease .", "label": "", "metadata": {}, "score": "59.87912"}
{"text": "Conclusion .PCV10 was associated with high protection against vaccine - type carriage with 2p+0 and 3p+0 doses for children vaccinated before the second semester of life .", "label": "", "metadata": {}, "score": "59.889233"}
{"text": "[Links ] .Longini IM , Nizam A , Ali M , Yunus M , Shenvi N. Controlling endemic cholera with oral vaccines .PLoS Med 2007;4:e336 .", "label": "", "metadata": {}, "score": "59.94053"}
{"text": "Millar EV , O'Brien KL , Watt JP , et al .Effect of community - wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age : a cross - sectional study in a high - risk population .", "label": "", "metadata": {}, "score": "59.953346"}
{"text": "Input parameters were derived from emerging data available for pH1N1 influenza illness in the US in spring / summer 2009 , published data , and expert opinion and are described in more detail below ( Tables 1 , 2 ) and in supplemental materials ( Tables S1 , S2 ) .", "label": "", "metadata": {}, "score": "60.024918"}
{"text": "Children with missing isolate serotype results were excluded from the analysis .Confounding variables related with both , vaccine uptake and the outcome of interest ( vaccine - type carriage ) were included into the multiple regression model to estimate adjusted RR .", "label": "", "metadata": {}, "score": "60.029392"}
{"text": "Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years : global estimates .Lancet 374 : 893 - 902 .doi : 10.1016/s0140 - 6736(09)61204 - 6 . O'Brien KL , Nohynek H ( 2003 ) World Health Organization Pneumococcal Vaccine Trials Carriage Working G ( 2003 )", "label": "", "metadata": {}, "score": "60.089317"}
{"text": "Abstract 114 .Alexander E , Telfer P , Rashid H , et al .Nasopharyngeal carriage rate of Streptococcus pneumoniae in children with sickle cell disease before and after the introduction of heptavalent pneumococcal conjugate vaccine .", "label": "", "metadata": {}, "score": "60.105507"}
{"text": "Results by schedule from 11 observational , pre / postvaccine introduction studies ( 13 citations ) are shown in Figure 4 . 18 , 20 - 26 , 28 , 31 , 36 , 47 , 49 All observational studies used PCV7 .", "label": "", "metadata": {}, "score": "60.123596"}
{"text": "These studies also did not consider the number of doses [ 13,14,17,18,35].In Colombia - Latin America , 2 years after PCV7 vaccination using a 2p+1 dosing schedule , an important reduction on vaccine - type carriage was observed among vaccinated children aged 12 to 18 months [ 36].", "label": "", "metadata": {}, "score": "60.14666"}
{"text": "Reed C , Angulo FJ , Swerdlow D , Lipstitch M , Meltzer M , et al .( 2009 ) Estimates of the burden of 2009 pandemic influenza A(H1N1 ) - United States , April - July 2009 .", "label": "", "metadata": {}, "score": "60.151413"}
{"text": "PCV13 cross - protection against the non - vaccine serotype 6C is a possibility [ 42 ] , [ 43 ] .Considering that serotypes 6A and 19A are included within PCV13 , the use of this vaccine could further decrease carriage of common disease - causing serotypes .", "label": "", "metadata": {}, "score": "60.192238"}
{"text": "The effect of PCV vaccination on carriage is of interest , since it could play a significant role in the overall vaccine impact on morbidity and mortality through minimizing vaccine serotype transmission to the non - vaccinated population .", "label": "", "metadata": {}, "score": "60.41977"}
{"text": "The effect of PCV vaccination on carriage is of interest , since it could play a significant role in the overall vaccine impact on morbidity and mortality through minimizing vaccine serotype transmission to the non - vaccinated population .", "label": "", "metadata": {}, "score": "60.41977"}
{"text": "This will assist in diagnosis if you develop symptoms of TB after you return home and also allows preventive treatment if you become infected but not diseased during deployment ( ie .", "label": "", "metadata": {}, "score": "60.53482"}
{"text": "Conclusion : PCV10 was associated with high protection against vaccine - type carriage with 2p+0 and 3p+0 doses for children vaccinated before the second semester of life .", "label": "", "metadata": {}, "score": "60.55738"}
{"text": "Centers for Disease Control and Prevention ( CDC ) ( 2009 ) Use of influenza A ( H1N1 ) 2009 monovalent vaccine : recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2009 .", "label": "", "metadata": {}, "score": "60.560814"}
{"text": "Up to age 13 years-2 doses , with 3 months between the first and second dose .13 years and above-2 doses , with a minimum of 4 weeks between the first and second dose .", "label": "", "metadata": {}, "score": "60.563927"}
{"text": "From these , 3 primary doses reduced VT carriage more than 2 doses at 1 - 7 months following the series ( 1 study significant ; 2 borderline ) .", "label": "", "metadata": {}, "score": "60.606476"}
{"text": "There may be other drugs not listed that can affect rabies vaccine .Tell your doctor about all the prescription and over - the - counter medications you use , and other vaccines you receive .", "label": "", "metadata": {}, "score": "60.77453"}
{"text": "Scott JR , Millar EV , Lipsitch M , et al .Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities .", "label": "", "metadata": {}, "score": "60.864746"}
{"text": "Huang SS , Hinrichsen VL , Stevenson AE , Rifas - Shiman SL , Kleinman K , et al .( 2009 )Continued impact of pneumococcal conjugate vaccine on carriage in young children .", "label": "", "metadata": {}, "score": "60.938805"}
{"text": "Owing to data gaps , we relied on rough assumptions in estimating the costs for cholera management and for a vaccination campaign .The base - case estimates of both costs might be underestimates given the narrow scopes of cost items considered ( however , for vaccine cost - effectiveness considerations , underestimating both costs concurrently may have limited impact , since treatment and vaccination costs influence incremental cost - effectiveness ratios in opposite directions ) .", "label": "", "metadata": {}, "score": "60.97475"}
{"text": "We show that reactive vaccination using oral cholera vaccines could have been effective and cost - effective in halting a large - scale cholera outbreak .", "label": "", "metadata": {}, "score": "61.02674"}
{"text": "Are very ill .PPSV .You should not receive the PPSV if you : .Had a life - threatening allergic reaction to a previous dose of PPSV .", "label": "", "metadata": {}, "score": "61.1183"}
{"text": "The cost - effectiveness ratios for these subgroups ranged from $ 5,000-$18,000/QALY depending on age and risk .Cost - effectiveness ratios were least favorable for persons aged 65 years and older .", "label": "", "metadata": {}, "score": "61.14946"}
{"text": "Left untreated , rabies is almost always fatal .Affected wounds must be immediately washed as described below ( wound and skin infections ) .Post - exposure rabies prophylaxis for anyone who is not fully immunised consists of human rabies immune globulin ( HRIG ) and 5 doses of rabies vaccine .", "label": "", "metadata": {}, "score": "61.17903"}
{"text": "At a study visit on Day 56 , participants will undergo a medical history review , blood collection , and a nasal wash procedure .From November through March following each subject 's study participation , parents or guardians will report respiratory and/or febrile illnesses on a weekly basis via telephone calls to study researchers .", "label": "", "metadata": {}, "score": "61.179276"}
{"text": "If your child has not been vaccinated or missed a dose , talk to the doctor .Depending on your child 's age , additional doses may be needed .", "label": "", "metadata": {}, "score": "61.205284"}
{"text": "In addition , seek medical advice if you have fever , chills , bloody diarrhoea or severe diarrhoea lasting more than 24 hours .Wound and skin infections .", "label": "", "metadata": {}, "score": "61.36176"}
{"text": "7 Nevertheless , the GAVI Alliance ( a public - private partnership to increase access to vaccines in the poorest countries ) has not prioritised support for cholera vaccines in developing countries before at least 2013 .", "label": "", "metadata": {}, "score": "61.41186"}
{"text": "Licensure of a 13-valent pneumococcal conjugate vaccine ( PCV13 ) and recommendations for use among children - Advisory Committee on Immunization Practices ( ACIP ) .", "label": "", "metadata": {}, "score": "61.517136"}
{"text": "Advisory Committee on Immunization Practices .Recommended adult immunization schedule : United States , 2011 .Ann Intern Med .Centers for Disease Control and Prevention .", "label": "", "metadata": {}, "score": "61.522263"}
{"text": "Nevertheless , cross - sectional studies of pneumococ- cal carriage could be a feasible , rapid and timely approach , when compared with follow - up studies for monitoring post - vaccination effects on pneumococcal serotype distributions .", "label": "", "metadata": {}, "score": "61.54422"}
{"text": "The most common complaints are : .Soreness or swelling around the injection site .Fever .Mild rash .Less commonly , seizure caused by fever , pneumonia , or other serious problems ( such as low blood count ) have been reported .", "label": "", "metadata": {}, "score": "61.619427"}
{"text": "Pneumococcal serotypes identified by Quellung reaction were described ( including those present in PCV10 and PCV13 composition ) .The main outcome of interest ( exposure variable ) was pneumococcal carriage of PCV10 vaccine type .", "label": "", "metadata": {}, "score": "61.790016"}
{"text": "Scott JA , Ojal J , Ashton L , et al .Pneumococcal conjugate vaccine given shortly after birth stimulates effective antibody concentrations and primes immunological memory for sustained infant protection .", "label": "", "metadata": {}, "score": "61.79621"}
{"text": "doi : 10.1097/inf.0000000000000076 What Is the Pneumococcal Vaccine ?Pneumococcal conjugate vaccine ( PCV)-Recommended for infants and toddlers .The PCV13 vaccine protects against 13 types of pneumococcal bacteria .", "label": "", "metadata": {}, "score": "61.82122"}
{"text": "Dagan R , Muallem M , Melamed R , et al .Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid .", "label": "", "metadata": {}, "score": "61.874146"}
{"text": "For more information , please refer to our Privacy Policy .Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine - type Nasopharyngeal Carriage .", "label": "", "metadata": {}, "score": "62.003586"}
{"text": "Avoid going out at dusk / dawn if possible but also remember that many species of mosquitoes may feed during the day , as well as at night .", "label": "", "metadata": {}, "score": "62.050217"}
{"text": "Cohen R , Levy C , Bingen E , et al .Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media .", "label": "", "metadata": {}, "score": "62.14102"}
{"text": "Base - case scenario for reactive vaccination using oral cholera vaccines .Decision - analytical approach .We developed a simple Excel - based model to calculate retrospectively the burden of the cholera outbreak in terms of disability - adjusted life years ( DALYs ) averted , with and without reactive vaccination using oral cholera vaccines ( Fig . 1 ) .", "label": "", "metadata": {}, "score": "62.174316"}
{"text": "Travel to certain countries may also increase your risk of exposure to rabies .Rabies human diploid cell vaccine is used to prevent rabies in people who have been bitten by an animal ( post - exposure ) or otherwise may be exposed to the rabies virus ( pre - exposure ) .", "label": "", "metadata": {}, "score": "62.193207"}
{"text": "Whitney CG , Pilishvili T , Farley MM , Schaffner W , Craig AS , et al .( 2006 )Effectiveness of seven - valent pneumococcal conjugate vaccine against invasive pneumococcal disease : a matched case - control study .", "label": "", "metadata": {}, "score": "62.212425"}
{"text": "Cohen R , Levy C , Bingen E , Koskas M , Nave I , et al .( 2012 ) Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media .", "label": "", "metadata": {}, "score": "62.31122"}
{"text": "Receipt of another investigational vaccine or investigational drug within 28 days of receiving this investigational RSV vaccine .Has received antibiotics or systemic or nasal steroid therapy or other prescription medications for acute illness within 3 days of study entry .", "label": "", "metadata": {}, "score": "62.3612"}
{"text": "It is not known whether rabies vaccine passes into breast milk or if it could harm a nursing baby .Do not use this medication without telling your doctor if you are breast - feeding a baby .", "label": "", "metadata": {}, "score": "62.398426"}
{"text": "Both clinical trials that evaluated 2 + 0 schedules after the first year of life demonstrated reductions in VT carriage .4 , 48 However , in 1 of these studies , the 2 + 1 schedule reduced VT carriage more than the 2 + 0 schedule at 1 of 3 time points , suggesting that the 2 + 1 schedule may be better than the 2 + 0 .", "label": "", "metadata": {}, "score": "62.407196"}
{"text": "Table 1 displays the categories of interest used to assess the RR and VE on PCV10 vaccine - type carriage .Among the 1,287 children enrolled , 707 ( 54.9 % ) were aged 7- 11 m and 678 ( 52.7 % ) were male .", "label": "", "metadata": {}, "score": "62.4526"}
{"text": "Fernandez J , Levine OS , Sanchez J , Baiter S , LaClaire L , et al .( 2000 )Prevention of Haemophilus influenzae Type b Colonization by Vaccination : Correlation with Serum Anti - Capsular IgG Concentration .", "label": "", "metadata": {}, "score": "62.474106"}
{"text": "Prymula R , Kriz P , Kaliskova E , et al .Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae - derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age .", "label": "", "metadata": {}, "score": "62.479156"}
{"text": "Of the 528 pneumococcal isolates , 494 ( 93.6 % ) were tested by Quellung reaction .Of these , 179 ( 36.2 % ) carried PCV10 vaccine - types .", "label": "", "metadata": {}, "score": "62.659355"}
{"text": "Conclusion PCV10 was associated with high protection against vaccine - type carriage with 2p+0 and 3p+0 doses for children vaccinated before the second semester of life .", "label": "", "metadata": {}, "score": "62.665817"}
{"text": "250/100 mg ; take 1 tablet daily orally with food starting 1 - 2 days before entering and continuing until 7 days after leaving a malarious area .", "label": "", "metadata": {}, "score": "62.696007"}
{"text": "Shrestha SS , Swerdlow D , Borse RH , Prabhu VS , Finelli L , et al .( 2011 ) Estimating the Burden of 2009 Pandemic Influenza A ( H1N1 ) in the United States ( April 2009-April 2010 ) .", "label": "", "metadata": {}, "score": "62.730865"}
{"text": "Results were sensitive to the number of vaccine doses needed , costs of vaccination , illness rates , and timing of vaccine delivery .Conclusions .", "label": "", "metadata": {}, "score": "62.824783"}
{"text": "Prosser LA , Bridges CB , Uyeki TM , Hinrichsen VL , Meltzer MI , et al .( 2006 ) Health benefits , risks , and cost - effectiveness of influenza vaccination of children .", "label": "", "metadata": {}, "score": "62.90674"}
{"text": "The PCV23 vaccine protects against 23 types of pneumococcal bacteria .The vaccines are made from inactivated bacteria .They are given by injection under the skin or into the muscle .", "label": "", "metadata": {}, "score": "62.936584"}
{"text": "Known hypersensitivity to any vaccine component .Lung or heart disease , including any wheezing event or reactive airway disease .Participants with clinically insignificant cardiac abnormalities requiring no treatment may be enrolled .", "label": "", "metadata": {}, "score": "62.952736"}
{"text": "Participant 's history has been reviewed and participant has undergone a physical examination indicating that s / he is in good health .In the view of the site investigator , the participant has received routine immunizations appropriate for their age .", "label": "", "metadata": {}, "score": "62.99392"}
{"text": "With the aim of assessing the direct effectiveness of PCV10 on pneumococcal carriage vaccine types , we conducted a cross - sectional study , during the first year of vaccination .", "label": "", "metadata": {}, "score": "63.058174"}
{"text": "With the aim of assessing the direct effectiveness of PCV10 on pneumococcal carriage vaccine types , we conducted a cross- sectional study , during the first year of vaccination .", "label": "", "metadata": {}, "score": "63.058174"}
{"text": "Early Assessment of VT Carriage During First Year of Life : Clinical Trials .Ten clinical trials evaluated 2- and 3-dose primary regimens during the first year of life compared with control subjects who received either placebo or no vaccine .", "label": "", "metadata": {}, "score": "63.21677"}
{"text": "Target population .The model includes cohorts of children and adults aged 6 months and older stratified by age and risk of complications .Age groups were : 6 - 23 month , 24 - 35 month ( 2 yrs ) , 3 - 4 years , 5 - 11 years , 12 - 17 years , 18 - 49 years , 50 - 64 years , and 65 years and older .", "label": "", "metadata": {}, "score": "63.275436"}
{"text": "Safranek TJ , Lawrence DN , Kurland LT , et al .( 1991 ) Reassessment of the association between Guillain - Barre syndrome and receipt of swine influenza vaccine in 1976 - 1977 : results of a two - state study .", "label": "", "metadata": {}, "score": "63.323837"}
{"text": "Bogaert D , van Belkum A , Sluijter M , Luijendijk A , de Groot R , et al .( 2004 )Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children .", "label": "", "metadata": {}, "score": "63.427757"}
{"text": "Tetanus / Diphtheria / Pertussis : Tetanus is not uncommon in the Asia - Pacific area following disasters .You need a booster dose unless you have received one within the last 5 years .", "label": "", "metadata": {}, "score": "63.438923"}
{"text": "Confounding variables related with both , vaccine uptake and the outcome of interest ( vaccine - type carriage ) were included into the multiple regression model to estimate adjusted RR .", "label": "", "metadata": {}, "score": "63.54978"}
{"text": "The first study , conducted in Fiji , compared 0 , 1 , 2 and 3 PCV7 doses ( given at 14 weeks , 6 and 14 weeks or 6 , 10 and 14 weeks , respectively ) with and without a PPV23 booster at 12 months .", "label": "", "metadata": {}, "score": "63.559822"}
{"text": "Pneumococci confirmed isolates were frozen and sent to the Streptococcus Laboratory , Centers for Disease Control and Prevention ( CDC ) for serotyping by Quellung reaction with CDC - prepared antisera .", "label": "", "metadata": {}, "score": "63.563065"}
{"text": "doi : 10.1016/j.vaccine.2011.05.034 .Scott JR , Millar EV , Lipsitch M , Moulton LH , Weatherholtz R , et al .( 2012 ) Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities .", "label": "", "metadata": {}, "score": "63.626656"}
{"text": "Lee BY , Brown ST , Korch GW , Cooley PC , Zimmerman RK , et al .A computer simulation of vaccine prioritization , allocation , and rationing during the 2009 H1N1 influenza pandemic .", "label": "", "metadata": {}, "score": "63.65288"}
{"text": "doi : 10.1086/315870 .Broome CV , Facklam RR , Fraser DW ( 1980 ) Pneumococcal disease after pneumococcal vaccination : an alternative method to estimate the efficacy of pneumococcal vaccine .", "label": "", "metadata": {}, "score": "63.838425"}
{"text": "van Gils EJ , Veenhoven RH , Hak E , et al .Effect of reduced - dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children : a randomized controlled trial .", "label": "", "metadata": {}, "score": "63.85354"}
{"text": "Take care when moving around the countryside and follow instructions from local police or military officers .Mosquito avoidance measures .Malaria , dengue fever and Japanese encephalitis are significant mosquito - borne diseases that you might be exposed to .", "label": "", "metadata": {}, "score": "63.855316"}
{"text": "National Network for Immunization Information website .Updated March 31 , 2010 .Accessed August 29 , 2013 .Recommended immunizations for adults by age .", "label": "", "metadata": {}, "score": "63.87036"}
{"text": "19 A fourth study , conducted in the Netherlands , compared children who received PCV7 at 2 and 4 months ( 2 + 0 ) ; 2 , 4 and 11 months ( 2 + 1 ) and unvaccinated controls .", "label": "", "metadata": {}, "score": "63.891678"}
{"text": "One , a clinical trial in Iceland , examined 81 children who received PCV8 conjugated to diphtheria or tetanus toxoid given in 3 primary doses ( 3 , 4 and 6 months ) and 40 unvaccinated controls .", "label": "", "metadata": {}, "score": "63.93478"}
{"text": "Estimated relative risk was calculated considering data reported from PCV clinical trial among children 9 months of age [ 31].Inclusion and Exclusion Criteria Sampled children were eligible to participate in the study if they lived in Goiania , had no prior antibiotic use during the previous seven days , and whose parent or legal guardian approved their child 's participation in the study with supplied informed consent signature .", "label": "", "metadata": {}, "score": "63.948673"}
{"text": "Yeh SH , Zangwill KM , Lee H , et al .Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants .", "label": "", "metadata": {}, "score": "64.02532"}
{"text": "Maps of the area .Information about the local area including a phrase book .Bed nets ( see below - mosquito avoidance measures ) .", "label": "", "metadata": {}, "score": "64.04433"}
{"text": "Exclusion Criteria : .Known or suspected impairment of immunological functions , including maternal history of positive HIV test .Receipt of immunosuppressive therapy including systemic corticosteroids within 30 days of study entry .", "label": "", "metadata": {}, "score": "64.06349"}
{"text": "At 6 , 12 and 17 months of age , VT carriage among the 2- and 3-dose groups was not significantly different .The receipt of a PPV23 booster showed no effect on VT carriage , as no difference in VT carriage at 17 months was seen between those who did and did not receive the PPV23 booster in each PCV dosing group .", "label": "", "metadata": {}, "score": "64.21942"}
{"text": "Drug information contained herein may be time sensitive .Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate , unless specifically indicated otherwise .", "label": "", "metadata": {}, "score": "64.24024"}
{"text": "Russell FM , Carapetis JR , Satzke C , et al .Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster .", "label": "", "metadata": {}, "score": "64.47155"}
{"text": "This document provides health advice about personal health protection to persons planning to travel to disaster - affected areas in the Asia - Pacific area as a member of an Australian government health team .", "label": "", "metadata": {}, "score": "64.53092"}
{"text": "This document provides health advice about personal health protection to persons planning to travel to disaster - affected areas in the Asia - Pacific area as a member of an Australian government health team .", "label": "", "metadata": {}, "score": "64.53092"}
{"text": "Finally , a pre / postintroduction study from France also included a sub - analysis examining the effect of the booster dose .28 PCV7 was licensed in France in 2001 and reimbursed for children with high - risk medical or living conditions in 2003 using a schedule of 2 , 3 and 4 months with a booster in the second year of life .", "label": "", "metadata": {}, "score": "64.58823"}
{"text": "Methods .Study Design .A cross - sectional population - based household survey was conducted .We measured PCV10 vaccination effect by comparing vaccinated and unvaccinated individuals , all of whom are covered by the same voluntary vaccination program [ 25 ] , [ 26 ] .", "label": "", "metadata": {}, "score": "64.614334"}
{"text": "( 2000 )Prevention of Haemophilus influenzae Type b Colonization by Vaccination : Correlation with Serum Anti - Capsular IgG Concentration .J Infect Dis 182 : 1553 - 1556 .", "label": "", "metadata": {}, "score": "64.63093"}
{"text": "Meeting of the Strategic Advisory Group of Experts on Immunization , October 2009 - conclusions and recommendations .Wkly Epidemiol Rec 2009;84(50):517 - 532 .[", "label": "", "metadata": {}, "score": "65.013504"}
{"text": "First , in studies with direct comparisons of 2 versus 3 primary doses , 3 doses result in a greater reduction in VT carriage compared with 2 doses at 1 - 7 months following the primary series .", "label": "", "metadata": {}, "score": "65.02034"}
{"text": "Because this was an observational study , we measured associations between PCV10 introduction and changes in pneumococcal vaccine - type carriage .This does not reflect causality , although data on potential confounding variables was collected and considered in the analysis .", "label": "", "metadata": {}, "score": "65.09445"}
{"text": "Because this was an observational study , we measured associations between PCV10 introduction and changes in pneumococcal vaccine - type carriage .This does not reflect causality , although data on potential confounding variables was collected and considered in the analysis .", "label": "", "metadata": {}, "score": "65.09445"}
{"text": "doi:10.1371/journal.pone.0098128 .Page 8 .Jansen AG , Hak E , Veenhoven RH , Damoiseaux RA , Schilder AG , et al .( 2009 ) Pneumococcal conjugate vaccines for preventing otitis media .", "label": "", "metadata": {}, "score": "65.14482"}
{"text": "Advisory Committee on Immunization P ( 2000 )Preventing pneumococcal disease among infants and young children .Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) .", "label": "", "metadata": {}, "score": "65.27307"}
{"text": "nausea , stomach pain .This is not a complete list of side effects and others may occur .Call your doctor for medical advice about side effects .", "label": "", "metadata": {}, "score": "65.30213"}
{"text": "These data suggest that 2 + 1 and 3 + 0 schedules may have similar effects on VT carriage after the first year of life , but these schedules were not directly compared in this study .", "label": "", "metadata": {}, "score": "65.32982"}
{"text": "Cholera is preventable by providing clean water and adequate sanitation , hygiene education , food safety , oral cholera vaccines , etc . , and readily treatable through oral rehydration therapy ( ORT ) .", "label": "", "metadata": {}, "score": "65.4922"}
{"text": "PLoS Med 8 : e1001107 . doi : 10.1371/journal.pmed.1001107 .Whitney CG , Goldblatt D , O'Brien KL ( 2014 )Dosing schedules for pneumococcal conjugate vaccine : considerations for policy makers .", "label": "", "metadata": {}, "score": "65.51676"}
{"text": "In conclusion , reactive vaccination has the potential to be a costeffective measure to control cholera outbreaks in some vulnerable countries at high risk .However , the feasibility of its implementation should be further evaluated , and caution is needed in transferring our findings to different settings .", "label": "", "metadata": {}, "score": "65.529755"}
{"text": "Vaccine 31 : 5634- 5642 .Franco CM , Andrade AL , Andrade JG , Almeida e Silva S , Oliveira CR , et al .", "label": "", "metadata": {}, "score": "65.53817"}
{"text": "Vaccine 31 : 4033 - 4038 .doi : 10.1016/j.vaccine.2013.04.074 .Fleming - Dutra KE , Conklin L , Loo JD , Knoll MD , Park DE , et al .", "label": "", "metadata": {}, "score": "65.593475"}
{"text": "The protocols will vary slightly in site selection requirements , eligibility requirements and site monitoring .These are all operational issues modified to account for the IMPAACT sites ' operations and infrastructure .", "label": "", "metadata": {}, "score": "65.593666"}
{"text": "Obaro SK , Adegbola RA , Chang I , et al .Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria , tetanus and pertussis vaccines in Gambian infants .", "label": "", "metadata": {}, "score": "65.59388"}
{"text": "Nevertheless , cross - sectional studies of pneumococcal carriage could be a feasible , rapid and timely approach , when compared with follow - up studies for monitoring post - vaccination effects on pneumococcal serotype distributions .", "label": "", "metadata": {}, "score": "65.6053"}
{"text": "-Rabies immune globulin may be given on day zero with the first post - exposure dose in previously unvaccinated patients ; not recommended for previously vaccinated patients .", "label": "", "metadata": {}, "score": "65.607056"}
{"text": "-Rabies immune globulin may be given on day zero with the first post - exposure dose in previously unvaccinated patients ; not recommended for previously vaccinated patients .", "label": "", "metadata": {}, "score": "65.607056"}
{"text": "Centers for Disease Control and Prevention ( 2010 )Licensure of a 13-valent pneumococcal conjugate vaccine ( PCV13 ) and recommendations for use among children - Advisory Committee on Immunization Practices ( ACIP ) .", "label": "", "metadata": {}, "score": "65.69321"}
{"text": "Abstract .Background : Pneumococcal conjugate vaccines ( PCV ) reduce nasopharyngeal carriage of vaccine type ( VT ) pneumococci , an important driver of vaccine programs ' overall benefits .", "label": "", "metadata": {}, "score": "65.724106"}
{"text": "Methods Study Design A cross - sectional population - based household survey was conducted .We measured PCV10 vaccination effect by comparing vaccinated and unvaccinated individuals , all of whom are covered by the same voluntary vaccination program [ 25,26].", "label": "", "metadata": {}, "score": "65.726074"}
{"text": "Contact your doctor for instructions if you miss a booster dose or if you get behind schedule .What should I avoid while receiving rabies vaccine ?", "label": "", "metadata": {}, "score": "65.77462"}
{"text": "Impact of the 10-valent pneumococcal non - typeable Haemophilus influenzae Protein D conjugate vaccine ( PHiD - CV ) on bacterial nasopharyngeal carriage .", "label": "", "metadata": {}, "score": "65.797775"}
{"text": "Impact of the 10-valent pneumococcal non - typeable Haemophilus influenzae Protein D conjugate vaccine ( PHiD - CV ) on bacterial nasopharyngeal carriage .", "label": "", "metadata": {}, "score": "65.797775"}
{"text": "This protocol is a companion study to P1114 ; a study being conducted by the Center for Immunization Research ( CIR , Johns Hopkins , Baltimore ) , and the Laboratory of Infectious Diseases ( NIAID , Bethesda ) .", "label": "", "metadata": {}, "score": "65.87108"}
{"text": "We used a decision analytic model , built using standard software ( TreeAge Pro 2009 Software , release 1.0 , Treeage Software , Williamstown , MA ) , to estimate costs and health outcomes for pH1N1 influenza vaccination compared to no vaccination .", "label": "", "metadata": {}, "score": "66.0122"}
{"text": "Unvaccinated : Children who did not receive any dose or those who received only one dose before 12 months of age ( for which , there was a recommendation of two or three doses ) .", "label": "", "metadata": {}, "score": "66.043594"}
{"text": "While no published studies directly compare the impact of 2 + 1 and 3 + 0 schedules on VT carriage , both schedules reduce VT carriage compared with no PCV use .", "label": "", "metadata": {}, "score": "66.092476"}
{"text": "Scott JR , Millar EV , Lipsitch M , Moulton LH , Weatherholtz R , et al .( 2012 ) Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities .", "label": "", "metadata": {}, "score": "66.10811"}
{"text": "Continued impact of pneumococcal conjugate vaccine on carriage in young children .Pediatrics 124 : e1 - 11 .doi : 10.1542/peds.2008 - 3099 .", "label": "", "metadata": {}, "score": "66.21303"}
{"text": "For 9.1 % of children , vaccination cards were not available .Thus , vaccination dates were obtained from Goiania 's Vaccination Online Database managed by the Munic- ipal Data Processing Company , which is a comprehensive database , with high completeness , and updated on time by vaccination workers at the moment of vaccine administration in vaccination services .", "label": "", "metadata": {}, "score": "66.27013"}
{"text": "Schedules Recommended by the Brazilian Immunization Program PCV10 was made available free of charge to all children in Brazil through its introduction into the Public Healthcare System ( Sistema U\u00b4nico de Sau \u00b4 de , SUS ) during March to October of 2010 in all municipalities .", "label": "", "metadata": {}, "score": "66.3542"}
{"text": "Lee BY , Brown ST , Cooley PC , Zimmerman RK , Wheaton WD , et al .( 2010 )A computer simulation of employee vaccination to mitigate an influenza epidemic .", "label": "", "metadata": {}, "score": "66.362885"}
{"text": "You should not receive this vaccine if you have ever had a life threatening allergic reaction to a rabies vaccine .Before receiving this vaccine , tell the doctor if you have : . a weak immune system caused by disease ( such as cancer , HIV , or AIDS ) ; . a history of allergic reaction to neomycin ( Mycifradin , Neo Fradin , Neo Tab ) ; or .", "label": "", "metadata": {}, "score": "66.37924"}
{"text": "The modeled target population included hypothetical cohorts of persons aged 6 months and older stratified by age and risk .The analysis used a one - year time horizon for most endpoints but also includes longer - term costs and consequences of long - term sequelae deaths .", "label": "", "metadata": {}, "score": "66.379745"}
{"text": "Our findings should be carefully interpreted when considered for different settings , since some parameter values may be specific to the size and severity of the Zimbabwe outbreak and demographics ( e.g. age - specific life expectancy ) , and epidemiology may vary by country .", "label": "", "metadata": {}, "score": "66.410355"}
{"text": "Flasche S , Van Hoek AJ , Sheasby E , et al .Effect of pneumococcal conjugate vaccination on serotype - specific carriage and invasive disease in England : a cross - sectional study .", "label": "", "metadata": {}, "score": "66.58029"}
{"text": "Member of a household that includes an immunocompromised individual or infants less than 6 months of age .Attends day care with infants less than 6 months of age , and whose parent / guardian is unable or unwilling to suspend daycare for 14 days following immunization .", "label": "", "metadata": {}, "score": "66.68463"}
{"text": "Deloria Knoll M , Park DE , Johnson TS , et al .Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity .", "label": "", "metadata": {}, "score": "66.70009"}
{"text": "Data Analysis .Because the included studies used various designs and methods , we were unable to perform a meta - analysis .Thus , we summarized the data across studies in descriptive analyses to provide an overview of the amount and variability of data by schedule .", "label": "", "metadata": {}, "score": "66.717804"}
{"text": "Do not start using a new medication without telling your doctor .Where can I get more information ?Your doctor or pharmacist may have additional information about rabies vaccine ( human diploid cell ) .", "label": "", "metadata": {}, "score": "66.776054"}
{"text": "( 2012 ) Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media .Pediatr Infect Dis J 31 : 297 - 301 .", "label": "", "metadata": {}, "score": "66.799576"}
{"text": "Dubos F , Marechal I , Husson MO , et al .Hospital Network for Evaluating the Management of Common Childhood Diseases .Decline in pneumococcal meningitis after the introduction of the heptavalent - pneumococcal conjugate vaccine in northern France .", "label": "", "metadata": {}, "score": "66.8337"}
{"text": "Cancer , leukemia , lymphoma , or multiple myeloma .Nephrotic syndrome .An organ or bone marrow transplant .Been taking medication that lowers immunity , such as chemotherapy or long - term steroids .", "label": "", "metadata": {}, "score": "66.86062"}
{"text": "Following PCV7 introduction , a reduction in pneumococcal carriage of PCV7 serotypes was described , as well as an increase in colonization by non - PCV7 serotypes [ 13,14].", "label": "", "metadata": {}, "score": "66.864624"}
{"text": "Insect repellent ( containing DEET or picaridin ) ; sunglasses ; sunscreen ( SPF 30 + ) ; wide - brimmed hat .Toilet paper ; condoms ; women need to take supplies of tampons etc . .", "label": "", "metadata": {}, "score": "66.94326"}
{"text": "Wenger J , Bruden D , Rudolph K , et al .Pneumococcal carriage and invasive pneumococcal disease in Alaska through the 7-valent pneumococcal conjugate vaccine era - 1998 - 2008 .", "label": "", "metadata": {}, "score": "66.95779"}
{"text": "It may cause nausea or diarrhoea in some people .Gastrointestinal diseases .Water : Functioning municipal water supplies may have been disrupted by a disaster .", "label": "", "metadata": {}, "score": "67.00924"}
{"text": "Halloran ME , Longini IM , Struchiner CJ ( 2010 ) Design and analysis of vaccine studies .New York : Springer .390 p. 26 .", "label": "", "metadata": {}, "score": "67.01083"}
{"text": "Blood - borne viruses .Take care with blood contact - hepatitis B virus is common and hepatitis C and HIV also occur .Take care with sexual contacts and always practice safe sex ( take condoms ) .", "label": "", "metadata": {}, "score": "67.070724"}
{"text": "Top of page .Immunisations recommended in some circumstances .Cholera : There is a risk of cholera in developing countries from contaminated water or food .", "label": "", "metadata": {}, "score": "67.10448"}
{"text": "Nohynek H , Makela H , Lucero M , et al .The impact of 11-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in Philippine children .", "label": "", "metadata": {}, "score": "67.17581"}
{"text": "A systematic sampling process was put in place , so that a proportional stratified random sample of children was obtained .Sampled children were assessed through home visits .", "label": "", "metadata": {}, "score": "67.22742"}
{"text": "A systematic sampling process was put in place , so that a proportional stratified random sample of children was obtained .Sampled children were assessed through home visits .", "label": "", "metadata": {}, "score": "67.22742"}
{"text": "PPSV is also given to anyone aged 2 to 64 who is taking a drug or treatment that lowers the body 's ability to resist infection , such as : .", "label": "", "metadata": {}, "score": "67.29886"}
{"text": "Parents / guardians who demonstrate their understanding of the study ( by taking the comprehension assessment ) , sign the informed consent , and agree to vaccine administration following detailed explanation of the study .", "label": "", "metadata": {}, "score": "67.36258"}
{"text": "Page 3 . 0.67 or more for a range of frequency of exposure among controls from 20 % to 70 % [ 29,30].Prevalence of pneumococcal carriage was obtained from a previous survey conducted in Goiania [ 27].", "label": "", "metadata": {}, "score": "67.37456"}
{"text": "The main endpoint for the study was the incremental cost - effectiveness ratio ( ICER ) calculated by dividing the net costs by the net health benefits ( as measured via QALYs ) for vaccination compared to no vaccination .", "label": "", "metadata": {}, "score": "67.40104"}
{"text": "Funding :Funding for this project was provided from the Harvard - CDC Joint Initiative in Vaccine Economics .The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention .", "label": "", "metadata": {}, "score": "67.453125"}
{"text": "Langmuir AD , Bregman DJ , Kurland LT , Nathanson N , Victor M ( 1984 )An epidemiologic and clinical evaluation of Guillian - Barre syndrome reported in association with the administration of swine influenza vaccines .", "label": "", "metadata": {}, "score": "67.49455"}
{"text": "One arm conducted among South African children with HIV who received a 3 + 0 PCV9 schedule had a nonsignificant increase in VT carriage when compared with controls .", "label": "", "metadata": {}, "score": "67.605194"}
{"text": "Use of combination measles , mumps , rubella , and varicella vaccine : recommendations of the Advisory Committee on Immunization Practices ( ACIP ) .MMWR Recomm Rep. 2010 May 7;59(RR-3):1 - 12 .", "label": "", "metadata": {}, "score": "67.74339"}
{"text": "Participants will receive one dose of the RSV cps2 vaccine administered as nose drops at study entry .Biological : RSV cps2 Vaccine .10 ^ 5.3 plaque forming units ( PFUs ) of RSV cps2 vaccine will be administered as nose drops ( 0.25 mL per nostril , for a total of 0.5 mL ) .", "label": "", "metadata": {}, "score": "67.75479"}
{"text": "[56 ] Baguelin et al .( 2010 ) use a dynamic model to evaluate vaccination against pandemic influenza A(H1N1 ) in England .[", "label": "", "metadata": {}, "score": "67.82387"}
{"text": "Results The prevalence of pneumococcal carriage was 41.0 % ( 95%CI : 38.4 - 43.7 ) .Serotypes covered by PCV10 and PCV13 were 35.2 % and 53.0 % , respectively .", "label": "", "metadata": {}, "score": "67.89857"}
{"text": "Effectiveness of seven - valent pneumococcal conjugate vaccine against invasive pneumococcal disease : a matched case - control study .Lancet 368 : 1495 - 1502 .", "label": "", "metadata": {}, "score": "67.94604"}
{"text": "Results .The prevalence of pneumococcal carriage was 41.0 % ( 95%CI : 38.4 - 43.7 ) .Serotypes covered by PCV10 and PCV13 were 35.2 % and 53.0 % , respectively .", "label": "", "metadata": {}, "score": "67.98358"}
{"text": "What other drugs will affect rabies vaccine ?Before receiving this vaccine , tell your doctor if you have recently received drugs or treatments that can weaken the immune system , including : . an oral , nasal , inhaled , or injectable steroid ; . chemotherapy or radiation cancer treatments ; . medications to treat psoriasis , rheumatoid arthritis , or other autoimmune disorders , such as azathioprine ( Imuran ) , etanercept ( Enbrel ) , leflunomide ( Arava ) , and others ; or . medicines to treat or prevent organ transplant rejection , such as basiliximab ( Simulect ) , cyclosporine ( Sandimmune , Neoral , Gengraf ) , muromonab CD3 ( Orthoclone ) , mycophenolate mofetil ( CellCept ) , sirolimus ( Rapamune ) , or tacrolimus ( Prograf ) .", "label": "", "metadata": {}, "score": "68.024"}
{"text": "Study Population and Sample For recruitment , the study targeted children of two age - groups : 7 - 11 months ( 7 - 11 m ) and 15 - 18 months ( 15 - 18 m ) .", "label": "", "metadata": {}, "score": "68.08706"}
{"text": "Thirty - four ( 6.6 % ) pneumococcal isolates could not be retrieved for serotyping .Simultaneous colonization with at least two pneumococcal serotypes was found in 17 ( 3.3 % ) children , six of which had a NT pneumococcal strain identified .", "label": "", "metadata": {}, "score": "68.14598"}
{"text": "Following PCV7 introduction , a reduction in pneumococcal carriage of PCV7 serotypes was described , as well as an increase in colonization by non - PCV7 serotypes [ 13 ] , [ 14 ] .", "label": "", "metadata": {}, "score": "68.16448"}
{"text": "We excluded studies with all vaccination series beginning after 12 months of life , studies that only reported data before or after PCV introduction but not for both periods and studies that did not report direct PCV effects on VT carriage .", "label": "", "metadata": {}, "score": "68.26347"}
{"text": "This article provides an overview of the well - established immunogenicity of PHiD - CV , including functional immune responses and immunologic memory , as well as immune responses in preterm infants and HIV - infected children .", "label": "", "metadata": {}, "score": "68.30552"}
{"text": "For 9.1 % of children , vaccination cards were not available .Thus , vaccination dates were obtained from Goiania 's Vaccination Online Database managed by the Municipal Data Processing Company , which is a comprehensive database , with high completeness , and updated on time by vaccination workers at the moment of vaccine administration in vaccination services .", "label": "", "metadata": {}, "score": "68.309265"}
{"text": "Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community - randomized trial .J Infect Dis .Hennessy TW , Singleton RJ , Bulkow LR , et al .", "label": "", "metadata": {}, "score": "68.32573"}
{"text": "Description of Included Studies .Of 12,980 citations reviewed , 145 had carriage data ; of these , 36 met inclusion criteria for VT carriage among children targeted to receive the vaccine ( Fig . 1 ) .", "label": "", "metadata": {}, "score": "68.38848"}
{"text": "Consult an experienced travel medicine doctor as early as possible about immunisations , malaria preventive therapy and other travel health advice .Consult a doctor ( even if you are one ) if you have a pre - existing medical condition , such as diabetes or epilepsy , for advice on whether you should join a relief team .", "label": "", "metadata": {}, "score": "68.4146"}
{"text": "For recruitment , the study targeted children of two age - groups : 7 - 11 months ( 7 - 11 m ) and 15 - 18 months ( 15 - 18 m ) .", "label": "", "metadata": {}, "score": "68.479675"}
{"text": "Black RE , Cousens S , Johnson HL , Lawn JE , Rudan I , et al .( 2010 )Global , regional , and national causes of child mortality in 2008 : a systematic analysis .", "label": "", "metadata": {}, "score": "68.51882"}
{"text": "Black RE , Cousens S , Johnson HL , Lawn JE , Rudan I , et al .( 2010 )Global , regional , and national causes of child mortality in 2008 : a systematic analysis .", "label": "", "metadata": {}, "score": "68.51882"}
{"text": "2p+0 : children who received two doses at any time during the first year of life ; .3p+0 : children who received three doses at any time during the first year of life ; .", "label": "", "metadata": {}, "score": "68.53154"}
{"text": "Start taking your malaria preventive therapy as directed ( see malaria prevention and treatment ) .What to take .Personal items .A passport ( and re - entry visa if applicable ) is essential ( even if you have been told it is not ) .", "label": "", "metadata": {}, "score": "68.56337"}
{"text": "To help avoid these infections it is important to clean any wounds , cuts or animal bites immediately and thoroughly .Wash with clean water and soap until the wound and surrounding area is visibly clean , ensuring that all dirt is removed .", "label": "", "metadata": {}, "score": "68.604256"}
{"text": "Comments : -Do not interrupt or discontinue because of local or mild systemic reactions ; these can usually be managed with anti - inflammatories , antihistamines , and anti - pyretics .", "label": "", "metadata": {}, "score": "68.61815"}
{"text": "Comments : -Do not interrupt or discontinue because of local or mild systemic reactions ; these can usually be managed with anti - inflammatories , antihistamines , and anti - pyretics .", "label": "", "metadata": {}, "score": "68.61815"}
{"text": "Roca A , Bottomley C , Hill PC , Bojang A , Egere U , et al .( 2012 )Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage .", "label": "", "metadata": {}, "score": "68.66502"}
{"text": "Roca A , Bottomley C , Hill PC , Bojang A , Egere U , et al .( 2012 )Effect of age and vaccination with a pneumococcal conjugate vaccine on the density of pneumococcal nasopharyngeal carriage .", "label": "", "metadata": {}, "score": "68.66502"}
{"text": "Samore M , Alder S , Haddadin B , et al .Effects of the heptavalent pneumococcal conjugate vaccine ( HV ) on serotype distribution and antimicrobial resistance of carriage pneumococcal ( Sp ) isolates from healthy children in rural communities .", "label": "", "metadata": {}, "score": "68.700584"}
{"text": "For this investigation , variables associated with crowding ( day - care attendance , and number of children in household ) , and mother 's schooling were identified as confounder ; in addition , age ( continuous variable ) was also entered into the model .", "label": "", "metadata": {}, "score": "68.702576"}
{"text": "For this investigation , variables associated with crowding ( day - care attendance , and number of children in household ) , and mother 's schooling were identified as confounder ; in addition , age ( continuous variable ) was also entered into the model .", "label": "", "metadata": {}, "score": "68.702576"}
{"text": "If you have not done so recently , have a dental check up before leaving .You may not be able to locate a dentist should you suffer an acute dental condition while deployed .", "label": "", "metadata": {}, "score": "68.73128"}
{"text": "Colonies with different morphol- ogies from each sample were analyzed separately .Pneumococci confirmed isolates were frozen and sent to the Streptococcus Laboratory , Centers for Disease Control and Prevention ( CDC ) for serotyping by Quellung reaction with CDC - prepared antisera .", "label": "", "metadata": {}, "score": "68.76862"}
{"text": "1Adjusted for no . of children in household , mother 's schooling , day - care attendance , and age ( as continuous variable ) .", "label": "", "metadata": {}, "score": "68.84463"}
{"text": "However , a study in France , conducted in the year following the switch from PCV7 to PCV13 , showed a significant reduction in the additional 6 serotypes included in PCV13 among children partially and fully vaccinated with PCV13 when compared with those vaccinated with PCV7 .", "label": "", "metadata": {}, "score": "68.85512"}
{"text": "We assessed the direct effectiveness of PCV10 vaccination in preventing nasopharyngeal / NP pneumococcal carriage in infants .Methods A cross - sectional population - based household survey was conducted in Goiania Brazil , from December/2010-February/2011 targeting children aged 7 - 11 m and 15 - 18 m. Participants were selected using a systematic sampling .", "label": "", "metadata": {}, "score": "68.90162"}
{"text": "( 1999 ) Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine .J Infect Dis 180 : 1171 - 1176 .Carvalho MG , Pimenta FC , Jackson D , Roundtree A , Ahmad Y , et al .", "label": "", "metadata": {}, "score": "68.977585"}
{"text": "Page 7 . serogroups 6A/6B and 6C/6D combined ) .A large number of isolates belonging to serogroup 6 was identified ( 26.6 % ) , as well as serotypes 19A and 19F ( 13.0 % ) .", "label": "", "metadata": {}, "score": "68.99135"}
{"text": "Participants will receive one dose of placebo administered as nose drops at study entry .Biological : Placebo Vaccine .Placebo vaccine will be administered as nose drops ( 0.25 mL per nostril , for a total of 0.5 mL ) .", "label": "", "metadata": {}, "score": "69.03209"}
{"text": "Palmu AA , Verho J , Makela PH , et al .Long - term efficacy of the seven valent PncCRM vaccine on nasopharyngeal carriage .", "label": "", "metadata": {}, "score": "69.19974"}
{"text": "[Links ] .Ali M , Emch M , von Seidlein L , et al .Herd immunity conferred by killed oral cholera vaccines in Bangladesh : A reanalysis .", "label": "", "metadata": {}, "score": "69.20415"}
{"text": "A Phase I Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live - Attenuated Respiratory Syncytial Virus Vaccine RSV cps2 , Lot RSV#005A , Delivered as Nose Drops to RSV - Seronegative Infants and Children 6 to 24 Months of Age .", "label": "", "metadata": {}, "score": "69.30983"}
{"text": "Results : The prevalence of pneumococcal carriage was 41.0 % ( 95%CI : 38.4 - 43.7 ) .Serotypes covered by PCV10 and PCV13 were 35.2 % and 53.0 % , respectively .", "label": "", "metadata": {}, "score": "69.382614"}
{"text": "Multum 's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to , and not a substitute for , the expertise , skill , knowledge and judgment of healthcare practitioners .", "label": "", "metadata": {}, "score": "69.42235"}
{"text": "The information contained within this advice is based upon best available evidence at the time of completion .What is rabies vaccine ?Rabies is a serious disease caused by a virus .", "label": "", "metadata": {}, "score": "69.44096"}
{"text": "Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children .Lancet 363 : 1871 - 1872 .doi : 10.1016/s0140 - 6736(04)16357 - 5 .", "label": "", "metadata": {}, "score": "69.466736"}
{"text": "We could not evaluate in depth the feasibility of achieving a high coverage rate among individuals of such a wide age range in a short time during a cholera crisis .", "label": "", "metadata": {}, "score": "69.54375"}
{"text": "Drink plenty of water and monitor your hydration ( e.g. , amount and colour of your urine ) .Include salty food in your diet ( ration packs normally provide this ) .", "label": "", "metadata": {}, "score": "69.58099"}
{"text": "Children are the major reservoir of this pathogen .Pneumococcal carriage is highest during the first two years of life , and its frequency varies according to geographic location and socioeconomic pattern [ 3 ] , [ 4 ] .", "label": "", "metadata": {}, "score": "69.6589"}
{"text": "Distribution of children within age - groups according to age at enrollment and age at first dose , Goiania , Dec/2010Feb/ 2011 .1Unvaccinated children were classified according to age at PCV10 introduction into National Immunization Program .", "label": "", "metadata": {}, "score": "69.704575"}
{"text": "When possible , the year of vaccine introduction was excluded from these calculations .We used Microsoft Access 2003 and 2007 ( Microsoft Corporation , Redmond , WA ) for data abstraction and SAS 9.2 and 9.3 ( SAS Institute Inc. , Cary , NC ) for analyses .", "label": "", "metadata": {}, "score": "69.89335"}
{"text": "Cochrane Database Syst Rev : CD001480 .Pilishvili T , Lexau C , Farley MM , Hadler J , Harrison LH , et al .( 2010 ) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine .", "label": "", "metadata": {}, "score": "69.9672"}
{"text": "This health advice is necessarily general and readers should not rely solely on the information contained within this advice .The information contained within this advice is not intended to be a substitute for advice from other relevant sources including , but not limited to , the advice from a health professional .", "label": "", "metadata": {}, "score": "70.016174"}
{"text": "Flasche S , Van Hoek AJ , Sheasby E , Waight P , Andrews N , et al .( 2011 )Effect of pneumococcal conjugate vaccination on serotype - specific carriage and invasive disease in England : a cross - sectional study .", "label": "", "metadata": {}, "score": "70.046715"}
{"text": "It can cause serious complications , especially in adults , newborns , or people with weak immune systems .VZV spreads from person to person by : .", "label": "", "metadata": {}, "score": "70.09972"}
{"text": "While it is difficult to directly compare cost - effectiveness analyses across countries due to differences in costs of services and level of intensity of care , results from other countries were consistent with ours in estimating favorable cost - effectiveness for mass vaccination in England and Canada .", "label": "", "metadata": {}, "score": "70.37173"}
{"text": "Data analysis Statistical analyses were performed using the STATA software , version 12.0 ( Stata Corp , College Station , TX ) .The distribution of children according to age - group at recruitment and at 1stPCV10 dose was compared .", "label": "", "metadata": {}, "score": "70.409676"}
{"text": "Please refer to this study by its ClinicalTrials.gov identifier : NCT01852266 Figures .Abstract .Background .10-valent conjugate pneumococcal vaccine / PCV10 was introduced in the Brazilian National Immunization Program along the year of 2010 .", "label": "", "metadata": {}, "score": "70.506775"}
{"text": "Miernyk K , Debyle C , Harker - Jones M , Hummel KB , Hennessy T , et al .( 2011 )Serotyping of Streptococcus pneumoniae isolates from nasopharyngeal samples : use of an algorithm combining microbiologic , serologic , and sequential multiplex PCR techniques .", "label": "", "metadata": {}, "score": "70.6328"}
{"text": "Get emergency medical help if you have any of these signs of an allergic reaction : hives ; difficult breathing ; swelling of your face , lips , tongue , or throat .", "label": "", "metadata": {}, "score": "70.6431"}
{"text": "This study will evaluate the safety and immune response to an RSV vaccine in healthy RSV - na\u00efve children .Allocation : Randomized Endpoint Classification : Safety Study Intervention Model : Parallel Assignment Masking : Double Blind ( Subject , Caregiver , Investigator , Outcomes Assessor ) Primary Purpose : Prevention .", "label": "", "metadata": {}, "score": "70.69638"}
{"text": "Yang Y , Sugimoto JD , Halloran ME , Basta NE , Chao DL , et al .( 2009 )The Transmissibility and Control of Pandemic Influenza A ( H1N1 ) Virus .", "label": "", "metadata": {}, "score": "70.77476"}
{"text": "Top of page .PRECAUTIONS WHILE YOU ARE DEPLOYED .Illness and injury are real possibilities when you are working overseas .If you develop any symptoms , seek medical advice immediately .", "label": "", "metadata": {}, "score": "70.80428"}
{"text": "Indirect effects ( i.e. , herd effects ) were not included in the primary analysis .The main endpoint was the incremental cost - effectiveness ratio in dollars per quality - adjusted life year ( QALY ) gained .", "label": "", "metadata": {}, "score": "70.83488"}
{"text": "Am J Epidemiol 133 : 940 - 951 .Schonberger LB , Bregman DJ , Sullivan - Bolyai JZ , et al .( 1979 ) Guillain - Barre syndrome following vaccination in the National Influenza Immunization Program , United States , 1976 - -1977 .", "label": "", "metadata": {}, "score": "70.85039"}
{"text": "doi : 10.1097/inf.0b013e318247ef84 .Grivea IN , Panagiotou M , Tsantouli AG , Syrogiannopoulos GA ( 2008 ) Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin - resistant Streptococcus pneumoniae among day - care center attendees in central Greece .", "label": "", "metadata": {}, "score": "70.88919"}
{"text": "Discussion To the best of our knowledge , data describing the impact of PCV10 on carriage after its introduction in routine schedule of NIPs has not yet been reported .", "label": "", "metadata": {}, "score": "70.89821"}
{"text": "Kellner JD , Scheifele D , Vanderkooi OG , Macdonald J , Church DL , et al .( 2008 ) Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with Streptococcus pneumoniae in children in Calgary , Canada .", "label": "", "metadata": {}, "score": "71.16153"}
{"text": "t002 Figure 1 .Distribution of pneumococcal serotypes carriage in children 7 - 18 months of age .Goiania , December/2010-February/ 2011 .Other serotypes : 9A , 9N , 10A , 15A , 17F , 18A , 20 , 21 , 22F , 23A , 23B , 24F , 25A , 28A , 29 , 31 , 33F , 34 , 35F. doi:10.1371/journal.pone.0098128 .", "label": "", "metadata": {}, "score": "71.17783"}
{"text": "O'Brien KL , Nohynek H , World Health Organization Pneumococcal Vaccine Trials Carriage Working G ( 2003 )Report from a WHO Working Group : standard method for detecting upper respiratory carriage of Streptococcus pneumoniae .", "label": "", "metadata": {}, "score": "71.24002"}
{"text": "One study of a 23-valent pneumococcal polysaccharide vaccine booster showed no effect .All 16 clinical trials with unvaccinated controls and 11 observational studies with before - after designs showed reduction in VT carriage .", "label": "", "metadata": {}, "score": "71.43943"}
{"text": "World Health Organization ( 2012 ) Pneumococcal vaccines WHO position paper .Wkly Epidemiol Rec 87 : 129 - 144 .Whitney CG , Pilishvili T , Farley MM , Schaffner W , Craig AS , et al .", "label": "", "metadata": {}, "score": "71.51104"}
{"text": "Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides .The information contained herein is not intended to cover all possible uses , directions , precautions , warnings , drug interactions , allergic reactions , or adverse effects .", "label": "", "metadata": {}, "score": "71.61589"}
{"text": "Local or US currency .Supply of any regular prescription medications to last the length of time you expect to be away .Spare prescription glasses or other prostheses .", "label": "", "metadata": {}, "score": "71.62805"}
{"text": "A household survey was conducted in the municipality of Goiania with 1,237 children , who were retroactively classified into one of three age groups , as a factor of the child 's age relatively to 30 days after PCV10 introduction .", "label": "", "metadata": {}, "score": "71.66226"}
{"text": "Potential impact of reactive vaccination in controllingcholera outbreaks : an exploratory analysis using a Zimbabwean experience .Sun - Young Kim I ; Yeongchull Choi III ; Peter R Mason IV ; Simbarashe Rusakaniko IV ; Sue J Goldie II .", "label": "", "metadata": {}, "score": "71.703705"}
{"text": "MMWR .Chickenpox vaccine : What you need to know .Centers for Disease Control and Prevention website .Updated March 13 , 2008 .Accessed November 28 , 2012 .", "label": "", "metadata": {}, "score": "71.72275"}
{"text": "( 2011 )Cost - Effectiveness of 2009 Pandemic Influenza A(H1N1 ) Vaccination in the United States .PLoS ONE 6(7 ) : e22308 .doi:10.1371/journal.pone.0022308 .", "label": "", "metadata": {}, "score": "71.72497"}
{"text": "54 ] Lee et al .( 2010 ) estimate averted lost productivity costs for an employee population but do not report results using an economic metric such as an incremental cost - effectiveness ratio making it difficult to compare these results with those from our study .", "label": "", "metadata": {}, "score": "71.89209"}
{"text": "Fleming - Dutra KE , Conklin L , Loo JD , Knoll MD , Park DE , et al .( 2014 ) Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine - type nasopharyngeal carriage .", "label": "", "metadata": {}, "score": "72.10109"}
{"text": "Kellner JD , Scheifele D , Vanderkooi OG , Macdonald J , Church DL , et al .( 2008 ) Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with Streptococcus pneumo- niae in children in Calgary , Canada .", "label": "", "metadata": {}, "score": "72.11491"}
{"text": "The rash usually develops on the face and trunk .Treatment generally focuses on reducing itchiness , such as using anti - itch cream .Antibiotics may be used for rashes that become infected .", "label": "", "metadata": {}, "score": "72.128586"}
{"text": "As reported by other studies , we also observed a high prevalence of NT carriage isolates [ 27,38,39].In addition to Quellung reaction for serotyping isolates , all NT pneumococci were tested by cmPCR .", "label": "", "metadata": {}, "score": "72.15945"}
{"text": "Use personal repellent containing high levels of DEET ( e.g. , Rid \u00ae , Tropical strength Aerogard \u00ae , Bushman 's \u00ae ) or picaridin ( Autan Repel \u00ae ) .", "label": "", "metadata": {}, "score": "72.176956"}
{"text": "Centers for Disease Control and Prevention website .Updated February 27 , 2013 .Accessed August 29 , 2013 .Pneumococcal disease .Immunization Action Coalition website .", "label": "", "metadata": {}, "score": "72.31589"}
{"text": "The critical parameter of interest was PCV10 uptake assessing as vaccine doses .Prevalence of pneumococcal carriage was estimated .Children with carriage of vaccine serotypes ( ' ' cases ' ' ) were compared with children that were negative for pneumococcal carriage ( ' ' non - cases ' ' ) .", "label": "", "metadata": {}, "score": "72.4118"}
{"text": "Ideally stick to the food supplied by the team .Handwashing , preferably with soap , after using the toilet , other potential contamination , and before preparing and eating food , is an important preventive measure .", "label": "", "metadata": {}, "score": "72.44073"}
{"text": "Cheung YB , Zaman SM , Nsekpong ED , et al .Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings .", "label": "", "metadata": {}, "score": "72.55231"}
{"text": "Citation : Andrade AL , Ternes YM , Vieira MA , Moreira WG , Lamaro - Cardoso J , Kipnis A , et al .( 2014 ) Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil .", "label": "", "metadata": {}, "score": "72.63815"}
{"text": "For pre- and postvaccine introduction observational studies among age groups targeted for vaccination , we calculated percent change in VT carriage by defining the baseline prevalence as the mean of all data points reported prior to introduction .", "label": "", "metadata": {}, "score": "72.641174"}
{"text": "Has received salicylate ( aspirin ) or salicylate - containing products within the past month .Infants born at less than 37 weeks gestation and less than 1 year of age .", "label": "", "metadata": {}, "score": "72.65528"}
{"text": "Articles published in 14 databases , from ad hoc unpublished sources and abstracts from meetings of the International Symposium on Pneumococci and Pneumococcal Disease ( 1998 - 2010 ) and the Interscience Conference on Antimicrobial Agents and Chemotherapeutics ( 1994 - 2010 ) , were searched .", "label": "", "metadata": {}, "score": "72.75115"}
{"text": "The critical parameter of interest was PCV10 uptake assessing as vaccine doses .Prevalence of pneumococcal carriage was estimated .Children with carriage of vaccine serotypes ( \" cases \" ) were compared with children that were negative for pneumococcal carriage ( \" non - cases \" ) .", "label": "", "metadata": {}, "score": "72.814064"}
{"text": "The 23-valent pneumococcal polysaccharide vaccine ( PPV23 ) , licensed in 1983 , protects against invasive pneumococcal disease ( IPD , infection of a normally sterile body site ) in adults , 3 but not against NP carriage .", "label": "", "metadata": {}, "score": "72.86995"}
{"text": "Children were swabbed only once .Specimens were collected with flexible perinasal calcium alginate swabs ( Fisherbrand , Fisher Scientific , Pittsburg , PA ) , which were placed into eppendorf tubes containing skim milk / tryptone / glucose / glycerol ( STGG ) trans- port medium [ 3].", "label": "", "metadata": {}, "score": "72.909904"}
{"text": "[Links ] .Murray CJL , Lopez AD , eds .The Global Burden of Disease .Vol . 1 of Global Burden of Disease and Injury Series .", "label": "", "metadata": {}, "score": "73.08789"}
{"text": "This work was supported in part by a Fogarty International Center Global Infectious Diseases Research Training Program grant , National Institutes of Health , to the University of Pittsburgh ( D43TW006592 ) .", "label": "", "metadata": {}, "score": "73.20276"}
{"text": "Estimating such costs using an ingredient approach ( numbers of units used multiplied by unit cost of each item ) is challenging , as no detailed data are available .", "label": "", "metadata": {}, "score": "73.43526"}
{"text": "Prevalence of pneumococcal carriage among children was estimated considering number of children colonized by S. pneumoniae in the numerator , and number of children surveyed for whom NP swabs were collected and processed in the denominator .", "label": "", "metadata": {}, "score": "73.45004"}
{"text": "To the best of our knowledge , data describing the impact of PCV10 on carriage after its introduction in routine schedule of NIPs has not yet been reported .", "label": "", "metadata": {}, "score": "73.52821"}
{"text": "Studies could have multiple arms .VT was defined as each study defined it , based on the product used .No studies included PCV products with serotype 19A ; none classified 19A as VT .", "label": "", "metadata": {}, "score": "73.589294"}
{"text": "Investigators identified primary data from the individual studies making up each study family for inclusion in the analysis .The primary data were selected as the most current and complete data available for that study family .", "label": "", "metadata": {}, "score": "73.616486"}
{"text": "Yellow fever immunisation is only recommended if travelling to affected areas in East Africa .There is no yellow fever in Asia or the Pacific .", "label": "", "metadata": {}, "score": "73.713486"}
{"text": "The medical treatment costs under reactive vaccination were based on the same approach but were assumed to decrease in proportion to the reduction in cholera cases / deaths due to vaccination ( summary Table I ) .", "label": "", "metadata": {}, "score": "73.74659"}
{"text": "Health outcomes and quality adjustments .The primary health outcome for the analysis is the quality - adjusted life year ( QALY ) .A QALY attempts to measure a patient 's physical health and well being including , among other factors , the ability to engage in \" normal , \" everyday activities .", "label": "", "metadata": {}, "score": "73.837074"}
{"text": "( 2011 )The 13-valent pneumococcal conjugate vaccine ( PCV13 ) elicits cross - functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine 29 : 7207 - 7211 .", "label": "", "metadata": {}, "score": "73.8549"}
{"text": "6 , 7 PCV use among children leads to simultaneous decreases in VT IPD and carriage in non - vaccinated age groups ( eg , adults ) , demonstrating that infant and toddler NP carriage is an important driver of pneumococcal transmission in the household and community . 8 Based on the precondition of NP carriage for development of disease and its role in transmission , the effect of PCV on VT carriage is important and may be used along with other data to infer PCV impact on disease .", "label": "", "metadata": {}, "score": "74.07175"}
{"text": "Pediatr Infect Dis J 22 : e1 - 11 .doi : 10.1097/01 .inf.0000049347.42983.77 .Bogaert D , van Belkum A , Sluijter M , Luijendijk A , de Groot R , et al .", "label": "", "metadata": {}, "score": "74.15411"}
{"text": "Spijkerman J , van Gils EJ , Veenhoven RH , Hak E , Yzerman EP , et al .( 2011 )Carriage of Streptococcus pneumoniae 3 years after start of vaccination program , the Netherlands .", "label": "", "metadata": {}, "score": "74.168594"}
{"text": "REFERENCES .O'Brien KL , Nohynek HWorld Health Organization Pneumococcal Vaccine Trials Carriage Working Group .Report from a WHO Working Group : standard method for detecting upper respiratory carriage of Streptococcus pneumoniae .", "label": "", "metadata": {}, "score": "74.17166"}
{"text": "( 2011 )The 13-valent pneumococcal conjugate vaccine ( PCV13 ) elicits cross - functional opsonophago- cytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A. Vaccine 29 : 7207 - 7211 .", "label": "", "metadata": {}, "score": "74.51927"}
{"text": "Vaccine Safety Datalink .Measles - mumps - rubella - varicella combination vaccine and the risk of febrile seizures .Pediatrics .2010 Jul;126(1):e1 - 8 .", "label": "", "metadata": {}, "score": "74.551254"}
{"text": "In addition to Quellung reaction for serotyping isolates , all NT pneumococci were tested by cmPCR .Considering that NT pneumococci recovered from carriage are often of non - encapsulated lineages , or can arise by mutations within cps genes or reduced gene expression , molecular tools are necessary for further characterization of NT strains [ 40 ] , [ 41 ] .", "label": "", "metadata": {}, "score": "74.57574"}
{"text": "Accessed August 29 , 2013 .Pneumococcal polysaccharide vaccine .Centers for Disease Control and Prevention website .Updated October 6 , 2009 .Accessed August 29 , 2013 .", "label": "", "metadata": {}, "score": "74.60618"}
{"text": "To protect your most sensitive data and activities ( like changing your password ) , we 'll ask you to re - enter your password when you access these services .", "label": "", "metadata": {}, "score": "74.6474"}
{"text": "Pediatr Infect Dis J 27 : 519 - 525 .Roca A , Hill PC , Townend J , Egere U , Antonio M , et al .", "label": "", "metadata": {}, "score": "74.65877"}
{"text": "Nasopharyngeal pneumococcal carriage of children attending day care centers in Korea : comparison between children immunized with 7-valent pneumococcal conjugate vaccine and non - immunized .", "label": "", "metadata": {}, "score": "74.709656"}
{"text": "23F ) .In 2010 , PCV10 ( including all serotypes in PCV7 plus 1 , 5 , 7F ) was made available and PCV7 was replaced by PCV13 ( including all serotypes in PCV10 plus 3 , 6A , and 19A ) [ 6 - 8].", "label": "", "metadata": {}, "score": "74.72179"}
{"text": "Citation : Andrade AL , Ternes YM , Vieira MA , Moreira WG , Lamaro - Cardoso J , et al .( 2014 ) Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil .", "label": "", "metadata": {}, "score": "74.731834"}
{"text": "Emerg Infect Dis 17 : 584 - 591 .doi : 10.3201/eid1704101115 .Tocheva AS , Jefferies JM , Rubery H , Bennett J , Afimeke G , et al .", "label": "", "metadata": {}, "score": "74.7383"}
{"text": "CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY .Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition .", "label": "", "metadata": {}, "score": "74.77528"}
{"text": "The team leader will normally ensure that the equipment and preventive measures you require are provided for you , however it is important to check that this is the case .", "label": "", "metadata": {}, "score": "74.94049"}
{"text": "Inclusion and Exclusion Criteria .We included data published from randomized controlled trials , nonrandomized trials , surveillance databases and observational studies of PCV schedules on VT carriage .", "label": "", "metadata": {}, "score": "75.11414"}
{"text": "Effect of pneumococcal conjugate vaccination on serotype - specific carriage and invasive disease in England : a cross - sectional study .PLoS Med 8 : e1001017 .", "label": "", "metadata": {}, "score": "75.33613"}
{"text": "S\u00e1 - Le\u00e3o R , Nunes S , Brito - Av\u00f4 A , et al .Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day - care centre attendees in Portugal , a country with widespread use of the seven - valent pneumococcal conjugate vaccine .", "label": "", "metadata": {}, "score": "75.37074"}
{"text": "Clin Vaccine Immunol 17 : 325 - 334 .doi : 10.1128/cvi.00435 - 09 .Flasche S , Van Hoek AJ , Sheasby E , Waight P , Andrews N , et al .", "label": "", "metadata": {}, "score": "75.37254"}
{"text": "Muhlemann K , Aebi S. Carriage of Streptococcus pneumoniae in Swiss infants , 2001 - 2007 .6th International Symposium on Pneumococci and Pneumococcal Disease ; June 8 - 12 , 2008 ; Reykjavik , Iceland .", "label": "", "metadata": {}, "score": "75.408966"}
{"text": "Brueggemann AB , Peto TE , Crook DW , et al .Temporal and geographic stability of the serogroup - specific invasive disease potential of Streptococcus pneumoniae in children .", "label": "", "metadata": {}, "score": "75.42531"}
{"text": "Full - text .DOI : \u00b7 Available from : Ruth Minamisava , Dec 23 , 2014 journal.pone.0098128 Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil.pdf ( 263.36 KB ) pone.0098128.pdf ( 263.36 KB ) .", "label": "", "metadata": {}, "score": "75.46333"}
{"text": "This analysis focused on VT carriage and did not address the effect of dosing schedules on all pneumococcal carriage or non - VT carriage , as the impact on VT carriage is the most important factor for policy makers when deciding which dosing schedules to recommend .", "label": "", "metadata": {}, "score": "75.49638"}
{"text": "Snake bite .There are many venomous snakes in the region and displaced snakes are likely to be a problem following flooding .Leave them alone .", "label": "", "metadata": {}, "score": "75.49748"}
{"text": "[Links ] .World Health Organization .Cholera vaccines : WHO position paper .Wkly Epidemiol Rec 2010;85(13):117 - 128 .[Links ] .", "label": "", "metadata": {}, "score": "75.52626"}
{"text": "Children ages were retrospectively calculated based on the date of the first received PCV10 dose .For unvaccinated children , ages were retrospectively calculated based on the date of PCV10 introduc- tion in Goiania Municipality ( June , 14th , 2010 ) .", "label": "", "metadata": {}, "score": "75.814896"}
{"text": "doi : 10.1097/inf.0b013e318168d28a .Roca A , Hill PC , Townend J , Egere U , Antonio M , et al .( 2011 )", "label": "", "metadata": {}, "score": "75.984955"}
{"text": "Emerg Infect Dis 19 : 589 - 597 .doi : 10.3201/eid1904.121198 . van den Bergh MR , Spijkerman J , Swinnen KM , Francois NA , Pascal TG , et al .", "label": "", "metadata": {}, "score": "76.118774"}
{"text": "Among the 32 studies , 25 ( 78 % ) were published in 2003 or later ; 17 ( 53 % ) were from Europe or North America ( Table 1 ) .", "label": "", "metadata": {}, "score": "76.14836"}
{"text": "To view content sources and attributions , please refer to our editorial policy .Related links .Share .SAMJ , S. Afr . med .", "label": "", "metadata": {}, "score": "76.180725"}
{"text": "Links ] .International Vaccine Institute .Oral cholera vaccine : First licensed vaccine developed with Gates Foundation support .[Links ] .Accepted 12 May 2011 .", "label": "", "metadata": {}, "score": "76.23645"}
{"text": "To provide stakeholders and policy makers with information on the potential value of oral cholera vaccines and to provoke discussion , we used the Zimbabwe outbreak to explore the cost - effectiveness of a hypothetical reactive vaccination from the global society perspective .", "label": "", "metadata": {}, "score": "76.260544"}
{"text": "Barros AJ , Hirakata VN ( 2003 )Alternatives for logistic regression in cross - sectional studies : an empirical comparison of models that directly estimate the prevalence ratio .", "label": "", "metadata": {}, "score": "76.26612"}
{"text": "A list of all children aged 7 - 11 m and 15 - 18 m resident in Goiania Municipality was obtained from the National Information System of Live Births with information on each child 's gender , date of birth , address , and mother 's name .", "label": "", "metadata": {}, "score": "76.62558"}
{"text": "A list of all children aged 7 - 11 m and 15 - 18 m resident in Goiania Municipality was obtained from the National Information System of Live Births with information on each child 's gender , date of birth , address , and mother 's name .", "label": "", "metadata": {}, "score": "76.62558"}
{"text": "Vestrheim DF , Hoiby EA , Aaberge IS , Caugant DA ( 2010 ) Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway .", "label": "", "metadata": {}, "score": "76.705414"}
{"text": "Abstract .Background .Pandemic influenza A(H1N1 ) ( pH1N1 ) was first identified in North America in April 2009 .Vaccination against pH1N1 commenced in the U.S. in October 2009 and continued through January 2010 .", "label": "", "metadata": {}, "score": "76.82419"}
{"text": "The authors have no competing interests to declare .Funding statement .This work was supported in part by the Center for Health Decision Science , Harvard School of Public Health .", "label": "", "metadata": {}, "score": "76.92125"}
{"text": "Mackenzie GA , Carapetis JR , Leach AJ , et al .Pneumococcal vaccination and nasopharyngeal bacterial carriage in Australian Aboriginal infants .5th International Symposium on Pneumococci and Pneumococcal Diseases ; April 2 - 6 , 2006 Alice Springs , Australia Abstract 251 .", "label": "", "metadata": {}, "score": "77.017365"}
{"text": "Direct contact with fluid from a varicella rash .It is most contagious just after the rash has broken out .It is also contagious 1 - 2 days before the rash erupts and until all of the blisters have crusted .", "label": "", "metadata": {}, "score": "77.064865"}
{"text": "Seek urgent medical attention if you experience symptoms of malaria including fever , chills , sweating , headache , muscle aches , cough , vomiting and diarrhea .", "label": "", "metadata": {}, "score": "77.18989"}
{"text": "A total of 528 children were positive by pneumococcal culture yielding an overall prevalence of pneumococcal carriage of 41.0 % ( 95 % CI : 38.4%-43.7 % ) .", "label": "", "metadata": {}, "score": "77.37155"}
{"text": "Dunais B , Bruno P , Carsenti - Dellamonica H , et al .Trends in nasopharyngeal carriage of Streptococcus pneumoniae among children attending daycare centers in southeastern France from 1999 to 2006 .", "label": "", "metadata": {}, "score": "77.44899"}
{"text": "BMC Med Res Methodol 3 : 21 .Zou G ( 2004 )A modified poisson regression approach to prospective studies with binary data .Am J of Epidemiol 159 : 702 - 706 .", "label": "", "metadata": {}, "score": "77.55424"}
{"text": "Serotyping of Streptococcus pneumoniae isolates from nasopharyngeal samples : use of an algorithm combining microbiologic , serologic , and sequential multiplex PCR techniques .J Clin Microbiol 49 : 3209 - 3214 .", "label": "", "metadata": {}, "score": "77.67072"}
{"text": "Nohynek H , Lucero MG , Ollgren J , et al .Upper respiratory tract ( URT ) pneumococcal ( PNC ) serotypes among Filipino children hospitalized for pneumonia or invasive pnc disease ( IPD ) .", "label": "", "metadata": {}, "score": "77.70342"}
{"text": "Lancet .Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine ( PPSV23 ) .MMWR Morb Mortal Wkly Rep. 2010;59(34):1102 - 1106 .", "label": "", "metadata": {}, "score": "77.76487"}
{"text": "VE was reported with 95 % confidence intervals ( 95%CIs ) .Statistical significance of VE was established if the lower limit of the 95 % CI around VE was greater than 0 ( zero ) .", "label": "", "metadata": {}, "score": "77.92577"}
{"text": "Clin Infect Dis 56 : e30 - 39 .Prymula R , Hanovcova I , Splino M , Kriz P , Motlova J , et al .", "label": "", "metadata": {}, "score": "78.02715"}
{"text": "The threat of cholera also looms over other vulnerable countries in Africa and other regions ( recent outbreaks in Pakistan and Haiti ) that face similar challenges .", "label": "", "metadata": {}, "score": "78.09616"}
{"text": "Sander B , Bauch CT , Fisman D , Fowler RA , Kwong JC , et al .( 2010 )Is a mass immunization program for pandemic ( H1N1 ) 2009 good value for money ?", "label": "", "metadata": {}, "score": "78.14435"}
{"text": "Humans get rabies when they are bitten by an infected animal .There may be no symptoms at first , but weeks or even years after a bite from an infected animal , rabies can cause pain , fatigue , headaches , irritability , fever , seizures , hallucinations , and paralysis .", "label": "", "metadata": {}, "score": "78.268936"}
{"text": "33 At mean ages of 35.2 months for vaccinated and 42.3 months for unvaccinated children , VT carriage was found in 4 ( 2 % ) of 200 vaccinated and 33 ( 16.5 % ) of 200 unvaccinated children .", "label": "", "metadata": {}, "score": "78.296326"}
{"text": "This was a retrospective cost - effectiveness analysis calculating the health and economic burden of the cholera outbreak in Zimbabwe with and without reactive vaccination .", "label": "", "metadata": {}, "score": "78.32962"}
{"text": "The only cholera vaccine available in Australia is Dukoral \u00ae ( Aventis Pasteur ) .Immunisation is recommended for anyone working in a refugee camp , and for other relief workers if a confirmed outbreak of cholera has been reported .", "label": "", "metadata": {}, "score": "78.40943"}
{"text": "Simultaneous colonization with at least two pneumococcal serotypes was found in 17 ( 3.3 % ) children , six of which had a NT pneumococcal strain identified .", "label": "", "metadata": {}, "score": "78.46278"}
{"text": "Measles : You will need measles - mumps - rubella ( MMR ) vaccine if you are not immune to measles .It is particularly important in this setting because of the increased likelihood of measles outbreaks .", "label": "", "metadata": {}, "score": "78.47826"}
{"text": "Doxycycline is preferred as it can also prevent other infections .Take 100 mg orally every day , starting 2 days before entering and continuing until 4 weeks after leaving a malarious area .", "label": "", "metadata": {}, "score": "78.55191"}
{"text": "Effects of community - wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia : a cluster - randomized trial .PLoS Med 8 : e1001107 .", "label": "", "metadata": {}, "score": "78.55767"}
{"text": "Kuo CY , Hwang KP , Hsieh YC , Cheng CH , Huang FL , et al .( 2011 )Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine .", "label": "", "metadata": {}, "score": "78.567314"}
{"text": "Kuo CY , Hwang KP , Hsieh YC , Cheng CH , Huang FL , et al .( 2011 )Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine .", "label": "", "metadata": {}, "score": "78.567314"}
{"text": "Emerg Infect Dis 19 : 589 - 597 .van den Bergh MR , Spijkerman J , Swinnen KM , Francois NA , Pascal TG , et al .", "label": "", "metadata": {}, "score": "78.63838"}
{"text": "Methods .A cross - sectional population - based household survey was conducted in Goiania Brazil , from December/2010-February/2011 targeting children aged 7 - 11 m and 15 - 18 m. Participants were selected using a systematic sampling .", "label": "", "metadata": {}, "score": "79.29434"}
{"text": "Jimenez R , de los Monteros LEE , Vargas F , et al .S. Pneumoniae dynamics of nasopharyngeal carriage after PCV7 vaccination .6th International Symposium on Pneumococci and Pneumococcal Disease ; June 8 - 12 , 2008 Reykjavik , Iceland Abstract 378 .", "label": "", "metadata": {}, "score": "79.303696"}
{"text": "What Is the Varicella Vaccine ?Varicella vaccine is a live virus vaccine that is given by injection .The varicella vaccine can also be given in a combination vaccine called the MMRV .", "label": "", "metadata": {}, "score": "79.57204"}
{"text": "The wired portion of the swab was cut at the top level of the tube , allowing the calcium alginate portion of the swab to drop into the vial .", "label": "", "metadata": {}, "score": "79.57486"}
{"text": "Sharma D , Thomas S , Jackson D , et al .Long term PCV7 impact on nasopharyngeal ( NP ) carriage of Streptococcus pneumoniae and invasive pneumococcal disease ( IPD ) among children in Atlanta .", "label": "", "metadata": {}, "score": "79.59676"}
{"text": "Base - case results .The total numbers of cholera cases and deaths reported during the Zimbabwe cholera crisis were translated into 78 240 DALYs ( discounted at 3 % ) .", "label": "", "metadata": {}, "score": "79.77791"}
{"text": "Five studies were statistically significant 20 , 22 , 23 , 28 , 31 and 3 studies ( 4 citations ) did not report statistical significance .", "label": "", "metadata": {}, "score": "79.77938"}
{"text": "Pediatr Infect Dis J 33 Suppl 2S152 - 160 .doi : 10.1097/inf.0000000000000083 .Miernyk K , Debyle C , Harker - Jones M , Hummel KB , Hennessy T , et al .", "label": "", "metadata": {}, "score": "79.80885"}
{"text": "Competing interests : The authors have declared that no competing interests exist .Introduction .2009 pandemic influenza ( A)H1N1 ( pH1N1)was first identified in Spring 2009 and has continued to circulate in North America and elsewhere .", "label": "", "metadata": {}, "score": "79.839066"}
{"text": "DRAFT 14 February 2007 .The purpose of this document is to provide information about personal health protection to people who are planning to travel to disaster - affected areas in the Asia - Pacific area as a member of an Australian government health team .", "label": "", "metadata": {}, "score": "79.89254"}
{"text": "Cultures for S. pneumoniae were performed for all STGG samples .The frozen vials containing the NP swabs in STGG were thawed at room temperature and then vigorously vortexed for 20 - 30 s. Alpha hemolytic colonies were tested for optochin susceptibility and bile solubility .", "label": "", "metadata": {}, "score": "79.95264"}
{"text": "Methods : We performed a systematic review of English language publications from 1994 to 2010 ( supplemented post hoc with studies from 2011 ) reporting PCV effects on VT carriage to assess variability in effect by dosing schedule .", "label": "", "metadata": {}, "score": "80.01401"}
{"text": "Schedules Recommended by the Brazilian Immunization Program .PCV10 was made available free of charge to all children in Brazil through its introduction into the Public Healthcare System ( Sistema \u00danico de Sa\u00fade , SUS ) during March to October of 2010 in all municipalities .", "label": "", "metadata": {}, "score": "80.63377"}
{"text": "Simell B , Auranen K , Kayhty H , Goldblatt D , Dagan R , et al .( 2012 )The fundamental link between pneumococcal carriage and disease .", "label": "", "metadata": {}, "score": "80.90872"}
{"text": "Lancet 2004;363:223 - 233 .[Links ] .Bhattacharya S , Black R , Bourgeois L , et al .The cholera crisi s in Africa .", "label": "", "metadata": {}, "score": "81.36772"}
{"text": "In 2010 , PCV10 was introduced into Brazil 's National Immunization Program ( NIP ) , with universal access for all children [ 20 ] .", "label": "", "metadata": {}, "score": "81.571396"}
{"text": "In 2010 , PCV10 was introduced into Brazil 's National Immunization Program ( NIP ) , with universal access for all children [ 20].", "label": "", "metadata": {}, "score": "81.571396"}
{"text": "[Links ] .Lucas ME , Deen JL , Seidlein L , et al .Effectiveness of mass oral cholera vaccination in Beira , Mozambique .", "label": "", "metadata": {}, "score": "81.66706"}
{"text": "M.D.K. has received support from Novartis for participation on a Data and Safety Monitoring Board , meeting travel reimbursement from Pfizer and grant support from Merck .", "label": "", "metadata": {}, "score": "81.72823"}
{"text": "RSV is the most common viral cause of serious acute lower respiratory illness ( LRI ) in infants and children under 5 years of age around the world .", "label": "", "metadata": {}, "score": "82.0282"}
{"text": "Data describing the impact of PCV10 vaccination on carriage are scarce and to date no significant effects of PCV10 on carriage have been described [ 22 ] , [ 23 ] .", "label": "", "metadata": {}, "score": "82.33786"}
{"text": "Prevalence of pneumococcal carriage was obtained from a previous survey conducted in Goiania [ 27 ] .We estimated that about 65 % would meet the study 's eligibility criteria ; therefore a total of 1,906 children were initially sampled .", "label": "", "metadata": {}, "score": "82.48436"}
{"text": "A large - scale cholera outbreak in Zimbabwe demonstrated how a preventable and easily treatable enteric disease can have disastrous outcomes that can be exacerbated by a weak health system infrastructure , sub - optimal availability of and access to basic water / sanitation , and lack of political will to improve the system .", "label": "", "metadata": {}, "score": "82.49308"}
{"text": "In 2010 , PCV10 ( including all serotypes in PCV7 plus 1 , 5 , 7F ) was made available and PCV7 was replaced by PCV13 ( including all serotypes in PCV10 plus 3 , 6A , and 19A ) [ 6 ] - [ 8 ] .", "label": "", "metadata": {}, "score": "82.54668"}
{"text": "Survey of nonsusceptible nasopharyngeal Streptococcus pneumoniae isolates in children attending day - care centers in Brazil .Pediatr Infect Dis J 29 : 77 - 79 .", "label": "", "metadata": {}, "score": "82.55229"}
{"text": "Survey of nonsusceptible nasopharyngeal Streptococcus pneumoniae isolates in children attending day - care centers in Brazil .Pediatr Infect Dis J 29 : 77 - 79 .", "label": "", "metadata": {}, "score": "82.55229"}
{"text": "doi : 10.1056/nejm198009043031003 .Spijkerman J , Prevaes SM , van Gils EJ , Veenhoven RH , Bruin JP , et al .( 2012 )", "label": "", "metadata": {}, "score": "82.60214"}
{"text": "J Infect Dis 180 : 1171 - 1176 .doi : 10.1086/315009 .Carvalho MG , Pimenta FC , Jackson D , Roundtree A , Ahmad Y , et al .", "label": "", "metadata": {}, "score": "83.18819"}
{"text": "In addition , SUS provided the vaccine for selected high risk individuals through its special immunization activities [ 20 ] .PCV10 Introduction and Schedules Evaluated at the Present Study . PCV10 vaccine was introduced in Goiania Municipality in June 14 th , 2010 .", "label": "", "metadata": {}, "score": "83.286705"}
{"text": "Just a belief that you have had measles infection or vaccination ( without evidence ) is not enough to assume immunity .Polio : Polio still occurs in India and has reemerged in Indonesia and some other parts of the world .", "label": "", "metadata": {}, "score": "83.3633"}
{"text": "Park IH , Kim KH , Andrade AL , Briles DE , McDaniel LS , et al .( 2012 )Nontypeable pneumococci can be divided into multiple cps types , including one type expressing the novel gene pspK. MBio 3 . e00035 - 12 .", "label": "", "metadata": {}, "score": "83.425934"}
{"text": "PHiD - CV has a safety and reactogenicity profile similar to that of other pneumococcal conjugate vaccines .[ Show abstract ] [ Hide abstract ] ABSTRACT : Pneumococcal 10-valent conjugate vaccine ( PCV10 ) was introduced to Brazil 's National Immunization Program ( NIP ) in 2010 .", "label": "", "metadata": {}, "score": "83.4762"}
{"text": "doi:10.1371/journal.pone.0098128 .Page 5 . differed ( p,0.05 ) in relation to number of children in household , mother 's schooling , and pneumococcal nasopharyngeal carriage .", "label": "", "metadata": {}, "score": "83.87556"}
{"text": "Late Assessment of VT Carriage After the First Year of Life : Clinical Trials .Thirteen clinical trials ( 14 citations ) assessed VT carriage with samples taken after the first year of life ( Fig .", "label": "", "metadata": {}, "score": "83.95384"}
{"text": "Lancet 369 : 1179 - 1186 .doi : 10.1016/s0140 - 6736(07)60564 - 9 .Jansen AG , Hak E , Veenhoven RH , Damoiseaux RA , Schilder AG , et al ..", "label": "", "metadata": {}, "score": "84.12064"}
{"text": "Although pneumococcal colonization is usually asymptomatic , in some cases , it progresses to a disease state , with spread from the nasopharynx resulting in sinusitis , otitis media , pneumonia and invasive diseases , such as bacteremia and meningitis .", "label": "", "metadata": {}, "score": "84.46292"}
{"text": "Center for Health Decision Science , Department of Health Policy and Management , Harvard School of Public Health , Boston , Massachusetts , USA , and Harvard Global Health Institute , Harvard University , Cambridge , Massachusetts , USA III MD , MPH , MBA .", "label": "", "metadata": {}, "score": "84.6694"}
{"text": "Nasopharyngeal ( NP ) swabs were collected from all children included in the study by trained research assistants during home visits .Children were swabbed only once .", "label": "", "metadata": {}, "score": "84.92795"}
{"text": "Methods : A cross - sectional population - based household survey was conducted in Goiania Brazil , from December/2010- February/2011 targeting children aged 7 - 11 m and 15 - 18 m. Participants were selected using a systematic sampling .", "label": "", "metadata": {}, "score": "85.136856"}
{"text": "To explore the potential impact of a hypothetical reactive oral cholera vaccination using the example of the recent large - scale cholera outbreak in Zimbabwe .", "label": "", "metadata": {}, "score": "85.16478"}
{"text": "Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition .", "label": "", "metadata": {}, "score": "85.172485"}
{"text": "Rabies is endemic in the region .Do not touch any animals ( wild or pets ) .Rabies - infected animals may exhibit unusually friendly behaviour , not just aggression .", "label": "", "metadata": {}, "score": "85.19705"}
{"text": "Connect .Subscribe to receive email notifications whenever new articles are published .This material is provided for educational purposes only and is not intended for medical advice , diagnosis or treatment .", "label": "", "metadata": {}, "score": "85.206345"}
{"text": "Wear loose cotton clothing for comfort in tropical climates .Remember that conservative dress sense is the social norm in most countries in Asia and that women should cover their shoulders .", "label": "", "metadata": {}, "score": "85.37955"}
{"text": "Clin Infect Dis 56 : e30 - 39 . doi : 10.1093/cid / cis922 .Prymula R , Hanovcova I , Splino M , Kriz P , Motlova J , et al .", "label": "", "metadata": {}, "score": "85.75603"}
{"text": "Results .From 1,906 children whose households were visited , 1,287 ( 67.5 % ) met the inclusion criteria and were included in the study .", "label": "", "metadata": {}, "score": "86.06737"}
{"text": "Wrote the paper : LAP TAL AEF CBB MIM .Centers for Disease Control and Prevention ( CDC ) ( 2009 )Update : infections with a swine - origin influenza A ( H1N1 ) virus -- United States and other countries , April 28 , 2009 .", "label": "", "metadata": {}, "score": "86.2408"}
{"text": "A rash of small , flat , red spots that become raised to form round , itchy , fluid - filled blisters .It takes about 10 - 21 days to develop varicella after contact with an infected person .", "label": "", "metadata": {}, "score": "86.66925"}
{"text": "Talk with your doctor and family members or friends about deciding to join a study .To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .", "label": "", "metadata": {}, "score": "86.691284"}
{"text": "The samples were sent immediately after collection to the Bacteriology Laboratory of the Federal University of Goias , Brazil , vortexed to disperse the organisms from the swab , and frozen at 280uC. Specimen Processing Cultures for S. pneumoniae were performed for all STGG samples .", "label": "", "metadata": {}, "score": "86.87518"}
{"text": "Major congenital malformations , including congenital cleft palate , cytogenetic abnormalities , or serious chronic disorders .Previous immunization with an RSV vaccine or previous receipt of or planned administration of any anti - RSV antibody product .", "label": "", "metadata": {}, "score": "87.06759"}
{"text": "4 , 29 , 35 , 42 Among the 29 arms reported in these 13 studies , 28 showed reduction in VT compared with control subjects ; 15 arms were statistically significant ( Fig .", "label": "", "metadata": {}, "score": "87.2767"}
{"text": "( 2013 ) Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogota , Colombia .", "label": "", "metadata": {}, "score": "87.51199"}
{"text": "Remember , keep this and all other medicines out of the reach of children , never share your medicines with others , and use this medication only for the indication prescribed .", "label": "", "metadata": {}, "score": "87.5663"}
{"text": "Pan American Health Organization .Technical Advisory Group on Vaccine - Preventable Diseases Technical Advisory Group on Vaccine - Preventable Diseases .Final Report ; July 6 - 8 , 2011 .", "label": "", "metadata": {}, "score": "87.607025"}
{"text": "doi : 10.1016/s0140 - 6736(06)69637 - 2 .Grijalva CG , Nuorti JP , Arbogast PG , Martin SW , Edwards KM , et al .", "label": "", "metadata": {}, "score": "87.64099"}
{"text": "Data describing the impact of PCV10 vaccination on carriage are scarce and to date no significant effects of PCV10 on carriage have been described [ 22,23].", "label": "", "metadata": {}, "score": "87.665054"}
{"text": "doi : 10.1186/1471 - 2288 - 3 - 21 .Mbelle N , Huebner RE , Wasas AD , Kimura A , Chang I , et al .", "label": "", "metadata": {}, "score": "87.985275"}
{"text": "doi : 10.1097/inf.0b013e3181658c5c .Huang SS , Hinrichsen VL , Stevenson AE , Rifas - Shiman SL , Kleinman K , et al .", "label": "", "metadata": {}, "score": "88.01458"}
{"text": "We did not consider any costs related to potential school closures or mandated absences from school or work due to illness .If these costs were appreciable , the results would be more favorable for vaccination if these additional costs of illness were included .", "label": "", "metadata": {}, "score": "88.08309"}
{"text": "doi : 10.1093/infdis / jir730 .Park IH , Kim KH , Andrade AL , Briles DE , McDaniel LS , et al .", "label": "", "metadata": {}, "score": "88.09827"}
{"text": "Study Location .Goiania is a highly urbanized municipality in Brazil , where there is a high rate of pneumococcal carriage and high vaccination coverage in infants [ 27 ] .", "label": "", "metadata": {}, "score": "88.342964"}
{"text": "Centers for Disease Control and Prevention website .Updated February 7 , 2011 .Accessed November 28 , 2012 .Varicella .EBSCO DynaMed website .", "label": "", "metadata": {}, "score": "88.39613"}
{"text": "Inclusion and Exclusion Criteria .Sampled children were eligible to participate in the study if they lived in Goiania , had no prior antibiotic use during the previous seven days , and whose parent or legal guardian approved their child 's participation in the study with supplied informed consent signature .", "label": "", "metadata": {}, "score": "88.42455"}
{"text": "The most common serious problem is motor vehicle trauma .Do not drink and drive .Wear your seat belt , follow the local customs and laws , avoid using bicycles and motor bikes ( wear a helmet if you must use them ) , and do n't board overcrowded vehicles .", "label": "", "metadata": {}, "score": "89.08117"}
{"text": "doi : 10.1016/s0140 - 6736(10)60549 - 1 . O'Brien KL , Wolfson LJ , Watt JP , Henkle E , Deloria - Knoll M , et al .", "label": "", "metadata": {}, "score": "89.4646"}
{"text": "Nontypeable pneumococci can be divided into multiple cps types , including one type expressing the novel gene pspK. MBio 3 : e00035 - 12 .doi : 10.1128/mbio.00035 - 12 .", "label": "", "metadata": {}, "score": "89.495605"}
{"text": "D.G. has received travel or honorarium support for participation in external expert committees for Merck , Sanofi Pasteur , Pfizer and GlaxosmithKline .K.O.B. received grant support from Pfizer , GlaxosmithKline and has received travel or honorarium support for participation in external expert committees for Merck , Aventis - pasteur and GlaxosmithKline .", "label": "", "metadata": {}, "score": "89.58421"}
{"text": "[Links ] .World Health Organization . cMYP database A new approach to planning for immunization - WHO - UNICEF guidelines for developing a comprehensive multi - year plan ( cMYP ) .", "label": "", "metadata": {}, "score": "89.76648"}
{"text": "Details on the search methods are provided elsewhere ( Methods Appendix 17 ) .Data Abstraction .Citations recovered through the literature search went through several stages of independent review to determine their eligibility , as described elsewhere ( Methods Appendix 17 ) .", "label": "", "metadata": {}, "score": "91.05458"}
{"text": "Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes .J Clin Microbiol 48 : 1611 - 1618 .", "label": "", "metadata": {}, "score": "91.48333"}
{"text": "Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes .J Clin Microbiol 48 : 1611 - 1618 .", "label": "", "metadata": {}, "score": "91.48333"}
{"text": "doi:10.1371/journal.pone.0098128 .Editor : Ray Borrow , Public Health England , United Kingdom .Received : March 3 , 2014 ; Accepted : April 29 , 2014 ; Published : June 3 , 2014 .", "label": "", "metadata": {}, "score": "91.69872"}
{"text": "PLoS One 7 : e39730 .doi : 10.1371/journal.pone.0039730 .Parra EL , De La Hoz F , Diaz PL , Sanabria O , Realpe ME , et al .", "label": "", "metadata": {}, "score": "91.73909"}
{"text": "United Nations , Department of Economic and Social Affairs , Population Division ( 2007 ) .World Population Prospects : The 2006 Revision .CD - ROM edition - extended dataset in Excel and ASCII formats ( United Nations publication , Sales No . E.07 .", "label": "", "metadata": {}, "score": "91.81737"}
{"text": "N Engl J Med 303 : 549 - 552 .Spijkerman J , Prevaes SM , van Gils EJ , Veenhoven RH , Bruin JP , et al .", "label": "", "metadata": {}, "score": "92.13704"}
{"text": "Accessed January 28 , 2008 .Cochrane Database Syst Rev. 2008;(3):CD001833 .Please be aware that this information is provided to supplement the care provided by your physician .", "label": "", "metadata": {}, "score": "92.17263"}
{"text": "The funders had no role in study design , data collection and analysis , decision to publish , or preparation of the manuscript .Competing interests : The authors state that ALA and MCCB have received travel grants from Pfizer and GSK for participation at meetings , and that this does not alter the authors ' adherence to PLOS ONE policies on sharing data and materials .", "label": "", "metadata": {}, "score": "92.303085"}
{"text": "For unvaccinated children , ages were retrospectively calculated based on the date of PCV10 introduction in Goiania Municipality ( June , 14 th , 2010 ) .", "label": "", "metadata": {}, "score": "93.49102"}
{"text": "Please be aware that this information is provided to supplement the care provided by your physician .It is neither intended nor implied to be a substitute for professional medical advice .", "label": "", "metadata": {}, "score": "93.79219"}
{"text": "Competing Interests : The authors state that ALA and MCCB have received travel grants from Pfizer and GSK for participation at meetings , and that this does not alter the authors ' adherence to PLOS ONE policies on sharing data and materials .", "label": "", "metadata": {}, "score": "94.40673"}
{"text": "Accessed November 28 , 2012 .Varicella ( chickenpox ) vaccination .US Centers for Disease Control and Prevention website .Updated April 5 , 2012 .", "label": "", "metadata": {}, "score": "94.91878"}
{"text": "doi : 10.1086/648593 .Spijkerman J , van Gils EJ , Veenhoven RH , Hak E , Yzerman EP , et al .( 2011 )", "label": "", "metadata": {}, "score": "95.06442"}
{"text": "Study Location The study was conducted in Goiania Municipality ( , 1,300 000 inhabs ) in the Central West region of Brazil .Goiania is a highly urbanized municipality in Brazil , where there is a high rate of pneumococcal carriage and high vaccination coverage in infants [ 27].", "label": "", "metadata": {}, "score": "95.14374"}
{"text": "Copyright 1996 - 2012 Cerner Multum , Inc.Version : 2.01 .Revision Date : 2012 - 09 - 13 , 9:23:14 AM .About .", "label": "", "metadata": {}, "score": "95.57145"}
{"text": "Author Contributions Conceived and designed the experiments : ALA CMT RM FOS AK MRC MCB FCP MGC .Performed the experiments : YMT JLC WGM IM MAV .", "label": "", "metadata": {}, "score": "95.67979"}
{"text": "47Thus , the potential for many replacing serotypes to cause IPD is not as high as for serotypes included by currently available PCV products .", "label": "", "metadata": {}, "score": "96.36062"}
{"text": "doi : 10.1111/j.1541 -0420.2012.01826.x .Franco CM , Andrade AL , Andrade JG , Almeida e Silva S , Oliveira CR , et al .", "label": "", "metadata": {}, "score": "96.54434"}
{"text": "doi:10.1371/journal.pone.0098128 Editor : Ray Borrow , Public Health England , United Kingdom Received March 3 , 2014 ; Accepted April 29 , 2014 ; Published June 3 , 2014 Copyright : ? 2014 Andrade et al .", "label": "", "metadata": {}, "score": "96.646515"}
{"text": "Author Contributions .Conceived and designed the experiments : ALA CMT RM FOS AK MRC MCB FCP MGC .Performed the experiments : YMT JLC WGM IM MAV .", "label": "", "metadata": {}, "score": "97.25508"}
{"text": "doi : 10.1093/cid / cis554 .Brasilia : Ministerio da Saude do Brasil .Acessed 10 August 2013 .Afonso ET , Minamisava R , Bierrenbach AL , Escalante JJ , Alencar AP , et al .", "label": "", "metadata": {}, "score": "98.732346"}
{"text": "4 The worst cholera outbreak affected all provinces in Zimbabwe and spread to South Africa , Mozambique , Zambia , Angola and Malawi .The Zimbabwean outbreak prompted a rethink about the most effective strategy to prevent and contain cholera outbreaks .", "label": "", "metadata": {}, "score": "99.505196"}
{"text": "Bras\u0131 \u00b4 lia : Ministerio da Saude do Brasil .exe?pni / cnv / cpnibr .def .Acessed 20 February 2014 .Barros AJ , Hirakata VN ( 2003 )", "label": "", "metadata": {}, "score": "100.28375"}
{"text": "Pneumococ- cal carriage is highest during the first two years of life , and its frequency varies according to geographic location and socioeco- nomic pattern [ 3,4].", "label": "", "metadata": {}, "score": "101.0054"}
{"text": "Accepted for publication August 13 , 2013 .Support for this project was provided by Program for Appropriate Technology in Health ( PATH ) through funding from the GAVI Alliance .", "label": "", "metadata": {}, "score": "101.03354"}
{"text": "The authors are very grateful to the anonymous reviewers for their extremely helpful comments on previous versions of the manuscript .References .Sack DA , Sack BR , Nair GB , Siddique AK .", "label": "", "metadata": {}, "score": "101.519035"}
{"text": "Contributed reagents / materials / analysis tools : YMT JLC WGM MCB IM FCP MGC .Wrote the paper : ALA YMT CMT FOS AK MRC MCB FCP MGC .", "label": "", "metadata": {}, "score": "103.334045"}
{"text": "Contributed reagents / materials / analysis tools : YMT JLC WGM MCB IM FCP MGC .Wrote the paper : ALA YMT CMT FOS AK MRC MCB FCP MGC .", "label": "", "metadata": {}, "score": "103.334045"}
{"text": "Ethical Considerations Written informed consent was obtained by the child 's legal parents / legal guardians .The protocol was approved by the Ethics Committee of the Federal University of Goias ( protocol # 145/ 2010 ) .", "label": "", "metadata": {}, "score": "105.60547"}
{"text": "This is an open - access article distributed under the terms of the Creative Commons Attribution - Non Commercial - No Derivatives 3.0 License , where it is permissible to download and share the work provided it is properly cited .", "label": "", "metadata": {}, "score": "105.676056"}
{"text": "Brasilia : Ministerio da Saude do Brasil .Acessed 10 August 2013 .Afonso ET , Minamisava R , Bierrenbach AL , Escalante JJ , Alencar AP , et al .", "label": "", "metadata": {}, "score": "105.93546"}
{"text": "If you 're using a public computer or you share this computer with others , we recommend that you uncheck the \" Remember me \" box .", "label": "", "metadata": {}, "score": "109.77706"}
{"text": "Conditions In Brief .What Is Varicella ?Varicella , commonly called chickenpox , is a highly contagious infection .It is caused by the varicella zoster virus ( VZV ) .", "label": "", "metadata": {}, "score": "114.65587"}
{"text": "Address for correspondence : Katherine E. Fleming - Dutra , MD , 1600 Clifton Road , NE , Mailstop C-25 , Atlanta , GA 30333 .", "label": "", "metadata": {}, "score": "116.97148"}
{"text": "This is an open - access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited .", "label": "", "metadata": {}, "score": "119.110855"}
{"text": "SG is partially supported by the Bill and Melinda Gates Foundation .The funding source did not have any influence on the design and conduct of the study .", "label": "", "metadata": {}, "score": "121.00623"}
{"text": "Acknowledgments .Author Contributions .Conceived and designed the experiments : LAP MIM .Performed the experiments : TAL .Analyzed the data : LAP TAL AEF CBB MIM .", "label": "", "metadata": {}, "score": "122.078995"}
{"text": "Buenos Aires , Argentina .What does \" Remember me \" mean ?By checking this box , you 'll stay logged in until you logout .", "label": "", "metadata": {}, "score": "124.47304"}
{"text": "The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .Publisher conditions are provided by RoMEO .", "label": "", "metadata": {}, "score": "125.73021"}
{"text": "Received : July 14 , 2010 ; Accepted : June 23 , 2011 ; Published : July 29 , 2011 .This is an open - access article , free of all copyright , and may be freely reproduced , distributed , transmitted , modified , built upon , or otherwise used by anyone for any lawful purpose .", "label": "", "metadata": {}, "score": "145.3378"}
